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1Introduction
There are three domains of life: archaea, bacteria and eukaryotes. The eukaryotes form the 
most anatomically diverse group, ranging in size and complexity from unicellular fungi to land 
plants,  insects  and vertebrates (Alberts  et  al.,  2002;  Campbell  and Reece,  2002). Due to this 
evolutionary plasticity of body plan, eukaryotes inhabit a large variety of biotopes and are the 
only one of the three domains to include organisms above the micrometer scale (Campbell and 
Reece, 2002). Unlike archaea and bacteria, eukaryotes possess numerous cellular compartments; 
these,  in  turn,  necessitate  elaborate  protein  sorting  and shuttling  mechanisms.  Understanding 
these mechanisms is essential for studying the biology of eukaryotic cells (Alberts et al., 2002).
The cell nucleus
The  hallmark  of  eukaryotic  evolution  is  compartmentalization,  especially  regarding 
genetic material (D'Angelo and Hetzer, 2008). Indeed, possession of an envelope-coated nucleus, 
which contains the cellular genome, is the defining trait of the eukaryotic domain (Alberts et al., 
2002).  The  nuclear  environment  enables  more  precise  regulation  of  gene  transcription  and 
alternative  splicing  of  gene  transcripts.  This,  in  turn,  makes  multicellularity  and  complex 
developmental patterns possible. Therefore, tight regulation of nuclear import and export is of 
critical importance (Alberts et al., 2002; Moreno et al., 2005; Elliott and Grellscheid, 2006).
2Functions of the NPC
The primary function of the NPC is selective transport of cargo, in and out of the nucleus 
(D'Angelo and Hetzer, 2008). Indeed, the nuclear pore complex is the only known mediator of 
nucleo-cytoplasmic traffic.  Nuclear proteins have to be imported from the cytoplasm. On the 
other hand, transcription products have to be exported from the nucleus (Suntharalingam and 
Wente, 2003).
A remarkable property of the NPC is its selectivity regarding transport of large molecules. 
Molecules with a diameter of about 9 nm or less (i.e. ions and biomolecules with a molecular 
mass of roughly 20-40 kDa or less (Schwartz, 2005)), pass through the NPC by diffusion. Larger 
molecules  can  only  pass  through  the  pore  via  an  active  transport  mechanism,  requiring  a 
specialized nuclear transport signal (Alberts et al., 2002). Several models have been proposed to 
explain the nature of the NPC selectivity (D'Angelo and Hetzer, 2008; Rout et al., 2000; Peters, 
2005; Bayliss et al., 2000).
Although selective upstream transport of molecules is an active process, the NPC itself 
lacks  any  known  structures  capable  of  active  transport.  Instead,  the  gradient  of  localized 
molecules  is  maintained  by  separate  systems  of  transport  factors  coupled  to  guanosine-
triphosphate  (GTP) hydrolyzing  molecules  (Rout  et  al.,  2000).  The  most  extensively  studied 
family of transport factors is the karyopherin-β family of transport factors coupled to a small 
GTP hydrolyzing protein, Ran. Different members of the karyopherin-β family recognize either a 
nuclear localization signals (NLS) or a  nuclear export signal (NES) on the surfaces of proteins 
intended for nuclear import or export. 
Export of mRNA is mediated by a different family of transport factors: the TAP-NXF 
family (Pemberton and Paschal, 2005; Fribourg et al., 2001; Matzat et al., 2008).
Although nucleo-cytoplasmic transport is the best known function of the NPC, it is far 
from being the only one. The NPC has been shown to function as a docking site for enzymes that 
regulate  important  processes  like  transcription,  DNA  replication  and  repair,  cell  death  and 
senescence,  chromosome  segregation  and  genome  stability.  Some  nucleoporins  have  been 
implicated in nuclear envelope mitotic disassembly and re-assembly processes and kinetochore 
binding (D'Angelo and Hetzer, 2008; Loïodice et al., 2004; Nagai et al., 2008; Orjalo et al., 2006; 
Menon et al. 2005). 
3Structure of the NPC
The NPC structure has been studied through proteomics,  biochemistry,  bioinformatics, 
electron microscopy and x-ray crystallography (Siniossoglou et al., 1996; Cronshaw et al., 2002; 
Rout et al., 2000; Alber et al., 2007; Yang et al., 1998; Kiseleva et al., 2004; Jeudy and Schwartz, 
2007; Hsia et al., 2007; Boehmer et al., 2008; Brohawn et al., 2008; Beck et al., 2007; Beck et al., 
2004). The molecular mass of this large, protein complex is estimated to be ~50 MDa and 60-80 
MDa in  yeast  and vertebrates,  respectively.  It  is  comprised  of  ~500 individual  proteins,  but 
consists of only ~30 different proteins, called nucleoporins or 'Nups' (Cronshaw et al., 2002; Rout 
et  al.,  2000; Alber et  al.,  2007). The NPC has a height  of 35-38 nm in yeast  and 80 nm in 
vertebrates,  making  it  higher  than  the  nuclear  envelope  (25-30  nm  in  yeast,  50-60  nm  in 
vertebrates), and diameter of 96 nm and 145 nm in yeast and vertebrates respectively.
The NPC is  a tripartite  structure,  consisting of a cytoplasmic  part,  nuclear  part  and a 
central  cylinder.  The cytoplasmic  and nuclear  parts  are  formed by bundles  of filaments.  The 
filaments on the cytoplasmic side radially emanate into the cytoplasm. The nuclear filaments join 
into a structure that has been termed the 'nuclear basket'. The central cylinder has an octagonal 
symmetry  axes  perpendicular  to  the nuclear  envelope plane,  dividing  the structure into  eight 
'spokes'. The most striking feature of the central cylinder is the central channel. It has a diameter 
of 49 nm and is filled with filamentous material. The central channel is the route of transport in 
and out of the nucleus for soluble  molecules.  Historically,  electron  microscopic  studies  have 
reported the existence of a cloud of electron density within the central  channel  (Yang et  al., 
Figure 1. A) A cryo-electron microscopic model of the Dyctiostelium NPC. Major structural features are outlined.  B) 
A simplified scheme of the metazoan NPC. Approximate localizations of nucleoporins are outlined. Schwartz 2005
A) B)
41998). This had been termed either the 'central plug' or 'central transporter', depending on the 
perceived function of the structure. Recent studies dismiss the 'central plug/transporter' as various 
cargo particles, trapped in the central channel during the electron microscopy preparation process 
(Peters, 2005; Beck et al., 2007; Tran and Wente, 2006) (Figure 1).
The central cylinder has been shown to consist of four ring systems: a central 'spoke ring', 
a 'membrane ring', partially located in the NE lumen and transversing the pore membrane and a 
pair  of  peripheral  rings,  located  on  the  cytoplasmic  and  nucleoplasmic  sides  of  the  central 
cylinder  and  accordingly  named  the  'cytoplasmic  ring'  and  the  'nuclear  ring'  (Akey  and 
Radermacher, 1993;  Beck et al., 2007;  Kiseleva et al., 2004).Overall, the volume of the yeast 
NPC is five times smaller than its vertebrate counterpart. However, symmetry, ring systems and 
other key structural elements (e.g. a central channel and filaments) of the NPC are conserved 
between yeast  and vertebrates  (Cronshaw et  al.,  2002;  Rout  et  al.,  2000;  Yang et  al.,  1998; 
Kiseleva et al., 2004). 
Although  the  detailed  arrangement  of  proteins  within  the  NPC  has  yet  to  be 
unambiguously determined (Alber et al., 2007; Hsia et al., 2007; Brohawn et al., 2008), it is well 
known that the NPC is composed of several subcomplexes such as the Nsp1, Nup84, Nup159/82 
and Nic96 subcomplexes in yeast (Nup62, Nup107-160, Nup214/88 and Nup93 subcomplexes in 
vertebrates,  respectively)  (D'Angelo  and  Hetzer,  2008;  Tran  and  Wente,  2006). These 
subcomplexes, in addition to being biochemically stable, remain stable throughout mitosis, when 
Figure 2. Model of the  NPC. A) A  cryo-electron microscopic reconstruction of the Dyctiostelium NPC. B) A highlight of the 
NPC  ring system . C) The approximate path of the nucleo-cytoplasmic cargo through the central channel. D) A model of the 
composition of the NPC. E) A suggestion of the fold distribution throughout the  NPC. (Alber et al., 2007)
A) B) C)
D) E)
5the NPC as a whole is disassembled (Loïodice et al., 2004). Localization of subcomplexes within 
the NPC using immunoelectron microscopy has revealed that the Nup107-160 subcomplex is a 
part of the central spoke rings and Nup214/88 forms the cytoplasmic ring. Additionally, another 
nucleoporin,  Tpr  has  been  localized  to  the  nuclear  basket,  providing  a  map  of  approximate 
positions of Nups within the NPC (Schwartz, 2005) (Figure1).
Recently,  a  computational  study  based  on  a  wealth  of  biochemical,  biophysical  and 
structural data, has produced a model of the distribution of different proteins within the yeast 
nuclear pore complex that is in line with electron microscopic measurements (Alber et al., 2007; 
Figure2). According to this model, the central cylinder of the NPC is built in a highly modular 
fashion, essentially consisting of 32 repetitions of a single structural module. 
NPC proteins are predicted to possess eight types of folds, mostly composed of multiple, 
simple, repetitive units. These fold types are, in turn, partitioned into three groups, according to 
their  localization (Devos et  al.,  2006). Core scaffold proteins are believed to belong to three 
domain  architectures:  α-solenoids,  β-propellers  or  a  binary combination  of  both,  with  the  β-
propeller  located  amino-terminally.  X-ray  crystallographic  studies  showed,  however,  that  the 
predictions  do not  match  the  experimental  data  very well  (Boehmer  et  al.,  2008; Jeudy and 
Schwartz, 2007; Hsia et al., 2007; Brohawn et al., 2008).
The seven-bladed β-propeller was first identified in proteins containing a WD40 motif. 
However,  additional  nucleoporins  without  a  detectable  conservation  of  this  motif  in  their 
sequence have been found to  have  the  seven-bladed β-propeller  fold,  allowing for  improved 
prediction of nucleoporin structures and suggesting a significant evolutionary adaptability of this 
fold, regarding primary structure (Berke et al., 2004).
The  structural  core  of  the  central  cylinder  is  believed  to  consist  of  a  network  of  α-
solenoids. The flexibility of this fold is thought to insure the ability of the NPC to accommodate 
cargo  of  different  sizes  (Alber  et  al.,  2007;  Devos  et  al.,  2006).  However,  the  recent 
determination of structures for many of the components of the core scaffold revealed a novel α-
helical  fold  that  is  rigid,  rather  than  flexible,  putting  the  pre-existing  theories  of  NPC fold 
composition and flexibility in question (Boehmer et al., 2008; Jeudy and Schwartz, 2007; Hsia et 
al., 2007; Brohawn et al., 2008). 
Proteins lining the central channel possess an unstructured region, consisting of repeats 
rich in phenylalanine and glycine (termed the FG-repeats). The FG-repeats fill the interior of the 
central  channel  and  extend  into  the  cytoplasm and  nucleoplasm.  They form the  filamentous 
6matter observed in EM studies. Most of the FG-repeat proteins are anchored to either the inner 
rings or the linker nucleoporins of the central cylinder via coiled-coil-type anchoring domains. 
The FG-repeats are generally agreed to form a meshwork that serves as a selective barrier for 
nucleo-cytoplasmic  transport  (D'Angelo  and  Hetzer,  2008;  Rout  et  al.,  2000;  Peters,  2005; 
Bayliss et al., 2000).
7Nup84 subcomplex
The best characterized subcomplex of the NPC is the Nup84 subcomplex in yeast and its 
metazoan counterpart,  the Nup107-160 subcomplex (referred to as yNup84 and mNup107-160 
subcomplex,  respectively).  The  yNup84  subcomplex  consists  of  seven  proteins:  yNup133, 
yNup84,  ySec13,  yNup145C  (the  carboxy-terminal  part  of  yNup145  after  in  vivo 
autoproteolysis  ), yNup120, yNup85 and ySeh1 (Sec13 homolog 1). Their counterparts in the 
mNup107-160 subcomplex  are:  mNup133,  mNup107,  mSec13,  mNup96,  mNup160,  mNup75 
and mSeh1, respectively. Two additional Nups exist in the mNup107-160 subcomplex: mNup37 
and mNup43 (Boehmer et al., 2008; Rout et al., 2000; Loïodice et al., 2004; Belgareh et al., 2001; 
Vasu et al., 2001; Ratner et al., 2007).
Each NPC contains 16 copies of the yNup84 subcomplex, distributed equally between the 
cytoplasmic and nucleoplasmic side of the complex in the outer scaffold rings of the central 
cylinder. (Alber et al, 2007). It is a 500 kDa , Y-shaped structure, about 42 nm long and 25 nm in 
diameter  (Brohawn et  al.,  2008; Lutzmann et  al.,  2002 ).  The yNup84 subcomplex  has been 
reconstructed in vitro. The reconstitution experiment revealed the subcomplex to be composed of 
several  subcomponents.  Proteins  yNup145C  and  ySec13  form  a  soluble  heterodimer  when 
isolated from the rest of the yNup84 complex, as do yNup85 and ySeh1. Another pair of closely 
associated proteins is formed by yNup133 and yNup84. In the yNup84 subcomplex,  yNup84 
binds the ySec13/yNup145C pair making a yNup133/yNup84-ySec13/yNup145C heterotetramer. 
Both  this  heterotetramer  and  the  ySeh1/yNup85  heterodimer  bind  yNup120  to  form  the 
heptameric yNup84 subcomplex (Lutzmann et al., 2002 ). 
Progress  in  characterizing  the  yNup84  complex  has  been  made  via  crystallographic 
studies  of  the  bound  protein  pairs  mNup133/mNup107  (Boehmer  et  al.,  2008), 
yNup145C/mSec13 (Hsia et al., 2007) and yNup85/ySeh1 (Brohawn et al., 2008). 
As  predicted  for  WD40  containing  proteins  (Berke  et  al.  2004;  Devos  et  al.  2004), 
mSec13  and  ySeh1  assume  the  fold  of  a  β-propeller,  with  each  blade  consisting  of  four 
antiparallel β-strands; however, unlike the 'closed' structure of a typical seven-bladed β-propeller, 
both  of  these  proteins  form an  'open',  six-bladed  β-propeller.  The  seventh,  'insertion'  blade, 
composed of three β-strands, is provided by the interacting partner (yNup85 and yNup145C for 
ySeh1 and ySec13 respectively) (Brohawn et al., 2008; Hsia et al., 2007) .
8An interesting pattern comes to attention when structures of yNup145C and yNup85 are 
compared. Secondary structures of both of these proteins are, with the exception of their amino-
terminal  insertion  blades,  entirely  α-helical,  however,  they  do  not  assume  the  predicted  α-
solenoid fold. Instead, in yNup85, helices α1-α3 (counting from the amino terminus) and α12-
α19 form two strings of α-helices, zig-zagging in opposite directions, forming a structure termed 
'the trunk'. In between the two antiparallel strings, helices α4-α11 form a tight bundle capping the 
trunk, with helices α5-α10 positioned almost perpendicularly to the meandering helices of the 
trunk. This central bundle has been named 'the crown'. Together, the trunk and the crown form a 
cuboid, U-shaped structure with a profoundly irregular pattern of α-helices, very different from 
the ordered α-solenoid. A very similar arrangement of α-helices, with a distinct crown and trunk 
is visible in yNup145C. Both of these proteins possess a structurally uncharacterized, carboxy-
terminal domain. This domain is predicted to be mostly α-helical and is termed 'the tail'  and  is 
necessary for binding to yNup120 (Brohawn et al., 2008; Hsia et al., 2007).
The structure of another NPC component, yeast protein Nic96, shows striking similarity 
to yNup85 and yNup145C and conforms well to the crown-trunk-tail architectural model. Nic96 
is  an  important  linker  nucleoporin  and  a  component  of  the  inner  scaffold  ring  (Jeudy  and 
Schwartz, 2007; Alber et al., 2007). All three parts of Nic96 have been structurally characterized, 
providing an insight into the shape of the 'tail' part of the protein. The Nic96 tail consists of 11 α-
helices that pair in a similar manner to the helices in the trunk, although they do not make a U-
turn, but rather an irregular, kinked structure (Jeudy and Schwartz, 2007; Brohawn et al., 2008).
Comparison  of  the  Nic96  structure  to  the  structure  of  interacting  carboxy-terminal 
Figure 3. ACE-1 domains of Nic 96, Nup85, Nup145C, Nup84 and Sec31. (Brohawn et al., 2008)
9domains of mNup133/mNup107 reveals that the carboxy-terminal domain of mNup107 shares 
the arrangement of α-helices similar to that seen in the Nic96 tail, confirming the consistency of 
the crown-trunk-tail model and suggesting that the tails of yNup85 and yNup145C are organized 
in the same fashion. Computer models based on the data from the Nic96, yNup85 and yNup145C 
structures predict the rest of the yNup84 carboxy-terminal domain to assume the crown and trunk 
folds (Brohawn et al., 2008).
In  addition  to  binding  yNup120  and  ySec13,  yNup145C  also  binds  yNup84.  This 
interaction has been localized to conserved, hydrophobic α-helices in the crown segments of both 
proteins. Thus, yNup145C forms three contacts: to Sec13 via its amino-terminal insertion blade, 
to yNup120 via its tail and to yNup84 through a crown-crown interaction (Brohawn et al., 2008).
A further examination of known crystal structures reveals that the yeast protein Sec31 also 
possesses a crown and a trunk. This vesicular protein has an amino-terminal seven-bladed β-
propeller domain, followed by an insertion blade (serving as a contact site for ySec13), followed 
by a helical domain, assuming the crown and trunk folds. The carboxy-terminal region of Sec31 
is predicted to be α-helical, but contains a proline-rich region implicated in activating the GTPase 
activity  of  Sar1 (another  component  of  COPII  vesicles),  making  the exact  nature  of  its  fold 
uncertain (Fath et al., 2007; Brohawn et al., 2008; Bi et al., 2007).
Sec31  dimerizes  through  crown-crown  binding.  But  unlike  the  yNup145C/yNup84 
interaction,  this  is  a domain-swap interaction,  creating a 'mixed crown',  composed of crowns 
from the two proteins and topologically similar to the single crowns of yNup145C, yNup85 and 
yNic96  (Bi  et  al.  2007;  Brohawn  et  al.  2008).  Binding  of  Sec13  is  important  in  Sec31 
oligomerization,  as the Sec13 β-propeller  is inserted between the α-helical  an the β-propeller 
domains  of  Sec31  and interacts  with  both.  In  particular,  Sec13 helps  position  the  Sec31  β-
propeller into a orientation that enables Sec31 β-propeller dimerization (Bi et al. 2007). 
Because the crown-trunk-tail domain architecture is present in several components of a 
complex that coats the nuclear pore and in Sec31, which coats the COPII vesicles, it has been 
named the ACE 1 domain (Ancestral Coatomer Element 1) (Brohawn et al. 2008) (Figure 3). 
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Models  of  the  NPC  scaffold  structure  based  on  the  Nup84 
complex
Two radically different models of the NPC core scaffold have recently surfaced (Hsia et 
al., 2007; Brohawn et al., 2008). 
Based  on  the  structures  of  ySeh1/yNup85,  mSec13/yNup145C,  mNup107/mNup133 
complexes  and  a  wealth  of  biochemical  and  biophysical  information  on  protein  interactions 
within the yNup84/mNup107-160 complex, the Schwartz group (Brohawn et al. 2008) proposes a 
model of the Y-shaped yNup84 complex and of the structural scaffold of the NPC as a whole 
(Figure 4).  According  to  this  model,  the  longer  end of  the Y-shaped complex  is  formed  by 
yNup133 bound via its carboxy-terminal domain to the tail of yNup84. In turn, yNup84 binds 
yNup145C  by  a  crown-crown  interaction.  Through  its  tail,  yNup145C  also  interacts  with 
yNup120, which forms one of the shorter ends of the Y shaped structure. Also bound to yNup120 
Figure 4. Schwartz model of the NPC scaffold.  β-propeller domains 
are indicated as circles, crown, trunck and tail parts of ACE-1 domains 
are indicated in blue, orange and green. α-helical regions whose exact 
fold is unknown are depicted as gray rods. A) Arrangemant of the 
Nup84 complex particles into a network framing the NPC. The 
complexes are depicted as interacting via homotypic interactions 
directly. The central region is composed of scaffold ring nucleoporins, 
including Nic96. Exact composition of this region is far less known. B) 
A detailed view of the Nup84 complex, as proposed by the Schwartz 
model. Brohawn et al. 2008
A)
B)
1 1
is  yNup85,  forming  the  second  shorter  end  of  the  Y-structure.  Peripherally  bound  to  this 
predominantly  α-helical  complex  would  be  the  β-propeller  folds  of  ySec13,  ySeh1  and  the 
predicted amino-terminal β-propeller domain of yNup133. 
Hsia  et  al.  suggest  an  altogether  different  model  (Hsia  et  al.,  2007) (Figure  5). The 
rationale for this model is based on the structure of human Sec13 bound to yNup145C. The unit 
cell  of  the  hSec13/yNup145C  contains  a  heterooctamer  formed  by  interactions  of  four 
vSec13/yNup145C heterodimers and has a shape of a 285 Å long, slightly bent rod.
According to the model proposed by Hsia et al., eight of these rods, placed vertically with 
respect to the pseudo-mirror symmetry plane of the NPC, support four stacked rings composed of 
seven yNup84 complexes, bound in a head-tale fashion. The authors propose that ySeh1/yNup85 
form an additional rod, increasing the number of vertical poles to sixteen.
Figure 5. Model of the NPC scaffold 
proposed by Hsia et al. A) Linear 
arrangement of Nup84 complex units 
into a continuous wall. B) The structure 
in A) curves into a barrel-like structure 
providing a wall for the NPC(Hsia et 
al., 2007)
A)
B)
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Importance of Sec13 for NPC function
Strikingly different roles that Sec13 plays in the two proposed models of NPC structure 
make the question of its importance for NPC function especially interesting. Due to its double 
function as part of the NPC and of the COPII vesicle coat, deletion of Sec13 is lethal in yeast 
(Pryer et al., 1993), rendering loss of function analysis impossible. Therefore, very little is known 
about  the  significance  of  Sec13  for  NPC  structure,  function  or  stability.  A  Sec13  mutation 
(AA224S→K) that specifically disrupts localization of ySec13 to COPII vesicles in a temperature-
dependent fashion without disrupting localization to the NPC is lethal,  indicating that loss of 
ySec13 function in vesicle transport alone is enough to cause lethality (Siniossoglou et al., 1996). 
For this reason, a mutant ySec13 that would specifically bind Nup145C, but would not interact 
with Sec31 might be a good tool for probing the role of Sec13 in the NPC. An orthogonal mutant 
would be equally desirable.
Although in vitro, Nup145C is insoluble without Sec13, this does not prove that the same 
holds true in vivo. Sec13 homolog, Seh1 is necessary for Nup84 solubility in vitro (Lutzmann et 
al., 2002 ), but the Seh1 gene is not essential in yeast (Siniossoglou et al., 1996), demonstrating 
that Seh1 protein is not essential for functioning of yNup85  in vivo. The Sec13/Nup145C pair 
may prove to be similar. Further, this suggests that the role β-propeller nucleoporins playing the 
structure of the yNup84 complex could be marginal. 
Finding that a single mutation in the Sec13-Nup145C interface is sufficient for complete 
disruption of interaction might indicate that Sec13 binds the Nup145C insertion blade without 
strongly interacting with its trunk domain, suggesting high mobility of the Sec13 β-propeller in a 
manner reminiscent of a medieval flail weapon. Effects of such a mutant could be studied by in 
vivo localization of Sec13 labeled with a fluorescent probe (Osmani et el., 2006). Loss of Sec13 
localization to the NPC without a significant impact on cell growth would support a marginal role 
of Sec13 in the NPC. Lethality of the mutation disrupting Sec13 localization to the NPC would 
signify a critical role of Sec13 in NPC structure. Localization of the mutant Sec13 to the NPC 
despite  the  loss  of  Nup145C  binding  would  be  suggestive  of  additional,  as  yet  unknown 
interactions (Siniossoglou et al., 1996; Boehmer et al., 2008). Such interactions are not wholly 
inconceivable as β-propeller folds have already been implicated in protein interactions that do not 
utilize insertion blade binding (Bi et al. 2007). 
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One of the approaches for designing a mutant Sec13 that would bind exclusively to Sec31 
is to compare interfaces of Sec13-Sec31 and Sec13-Nup145C and find amino acids that can be 
mutated to selectively affect Sec13-Nup145C binding.
However, as the only extant structure of the Sec13/Nup145C complex is a hybrid between 
a human vSec13 and yeast  yNup145C (Hsia et  al.,  2007),  it  is of little  relevance for mutant 
design. Since two structures of ySec13 bound to ySec31 are known (Fath et al., 2007), a structure 
of the ySec13-yNup145C complex is needed for binding site comparison.
The goal of this project was obtaining a crystal structure of the yeast Sec13 in complex 
with the yNup145C insertion blade that would provide a clear view of the ySec13/yNup145C 
interface, i.e.  a structure with a resolution of <2.8  Å (Berg et al., 2002). The obtained 2.5 Å 
structure of the ySec13/yNup145C complex was compared to the structures of ySec13/ySec31. 
Based on the differences between the interaction sites of the two structures, a mutant ySec13 
protein was designed, that binds specifically to ySec31, but has lost affinity for yNup145C. The 
effect of this mutation was confirmed by in vitro experiments.
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Materials and methods
Materials
Standard chemicals
agar  (Sigma),  agarose  (EMD),  acetic  acid  (VWR),  acrylamide  (National  Diagnostocs),  ammonium 
persulphate, APS (VWR), ampicillin (VWR), bromophenol blue, BPB (VWR), chloramphenicol (VWR), 
Coomassie  Brilliant  Blue  R250  (Sigma),  dipotassium  phosphate  (Sigma),  dithiothreitol,  DTT  (Gold 
Biotechnology), ethanol, 100% p.a. (VWR), ethidium bromide (Sigma), ethylenediaminetetraacetic acid, 
EDTA (Sigma), glycerol (Sigma), glycine (), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, HEPES 
(Sigma),  imidazole  (Sigma),  isopropyl  alcohol  (VWR),  isopropyl  β-D-1-thiogalactopyranoside,  IPTG 
(Gold Biotechnology), lithium chloride (Sigma), monopotassium phosphate (Sigma), kanamycin (VWR), 
hydrochloric acid, 36% p.a. (VWR), 2-mercaptoethanol (VWR), N,N'-methylenebisacrylamide (National 
Diagnostocs),  phenylmethanesulphonylfluoride,  PMSF  (Sigma),  polyethylene  glycol  4000,  PEG  4K 
(Sigma),  sodium acetate  (Sigma),  sodium dodecyl  sulfate,  SDS (Sigma),  sodium hydroxide  (Sigma), 
sodium  chloride  (Sigma),  tetramethylethylenediamine,  TEMED  (Sigma), 
tris(hydroxymethyl)aminomethane , Tris (Sigma), urea (Sigma), xylene cyanol (Sigma)
Enzymes and other protein reagents
BamHI  (NEB),  BSA  (NEB),  DpnI  (NEB),  NdeI  (NEB),  NotI  (NEB),  PfuUltra  II  Fusion  HS  DNA 
Polymerase  (Stratagene),  PrescissionProtease  (GE  healthcare),  T4  Ligase  (NEB),  T4  Polynucleotide 
Kinase (NEB), XhoI (NEB)
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Strains and plasmids
For  plasmid  amplification  and  cloning,  the  Escherichia  coli DH5α  (supE44,  ΔlacU169 
(Φ80lacZΔM15),  recA1,  endA1,  hsdR17,  thi-1,  gyrA96,  relA1)  strain  was  used.  For  protein 
overexpression, the  E. coli BL21-RIL (F–,  ompT , hsdS(rB– mB–),  dcm+, Tetr,  gal, endA,  Hte [argU ileY 
leuW Camr]) strain was used. 
The pETDuet-1 (Figure 6) vector with cloned genes of interest was used in all experiments. pETDuet-1 is 
suitable  for  coexpression  of  two  genes  of  interest.  This  plasmid  contains  two  multiple  cloning  sites 
(MCS),  each of  which is  preceded by a T7 promoter/lac  operator and a ribosome binding site (rbs), 
thereby comprising two separate expression cassettes.  The first  MCS is  also preceded by a sequence 
coding  for  a  polyhistidine  (His6)  tag.  The  pETDuet-1  vector  also  carries  the  pBR322-derived  ColE1 
replicon, lacI gene and ampicillin resistance gene.
Following plasmids were derived from pETDuet-1:
pETDuet1-Sec13-Nup145C plasmid carrying a gene coding for Sec13 in the first expression cassette and 
a gene for Nup145C in the second cassette.
pETDuet1-Sec13/Nup145C (109-712)  plasmid carrying the gene coding for Sec13 fused to Nup145C 
amino acids 109-712 through a glycine (4x)-serine-glycine(4x) linker .
Figure 6. pETDuet-1 plasmid chart
C
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pETDuet1-Sec13/Nup145C (109-179)  plasmid  carrying  the gene coding for Sec13 fused to the gene 
coding for Nup145C amino acids 109-179 through a glycine (4x)-serine-glycine(4x) linker .
pETDuet1-Sec13(I12F)-Nup145C plasmid carrying a gene coding for Sec13 with a 12I→F mutation in 
the first expression cassette and the gene for Nup145C in the second cassette.
pETDuet1-Nup145C-Sec13  plasmid  carrying  the  gene  coding  for  Nup145C  in  the  first  expression 
cassette and the gene for Sec13 in the second cassette.
pETDuet1-Nup145C-Sec13(I12F) plasmid carrying the gene coding for Nup145C in the first expression 
cassette and the gene for Sec13 with the 12I→F mutation in the second cassette.
pETDuet1-Sec13-Sec31(372-411)  plasmid  carrying  the  gene coding for Sec13 in  the  first  expression 
cassette and a gene for Sec31 amino acids 372-411 in the second cassette.
pETDuet1-Sec13(I12F)-Sec31(372-411)  plasmid  carrying  the  gene  coding  for  Sec13  with  the  12I→F 
mutation  in  the  first  expression cassette  and the  gene for  Sec31 amino  acids  372-411 in  the  second 
cassette.
pETDuet1-Sec31(1-748)-Sec13 plasmid carrying a gene coding for a gene for Sec31 amino acids 1-748 
in the first expression cassette and Sec13 in the second cassette.
pETDuet1-Sec31(1-748)-Sec13(I12F) plasmid carrying the gene coding for a gene for Sec31 amino acids 
1-748 in the first expression cassette and Sec13 with the 12I→F mutation in the second cassette.
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Methods for working with DNA
Polymerase chain reaction
Polymerase Chain Reaction (PCR) is a method for in vitro amplification of DNA sequences. DNA 
primers and the DNA polymerase are pre-added to a PCR mixture, while cyclic variations in temperature 
serve  as  a  substitute  for  in  vivo replication  machinery:  different  temperatures  are  defined  for  strand 
separation,  primer  annealing  and  DNA  polymerization.  The  DNA  polymerase  used  is  usually  a 
thermostable protein isolated from thermophilic organisms Several modifications of PCR were used in this 
project.
iPCR
Inverse  PCR (iPCR)  was used in  producing the  pETDuet1-Sec13/Nup145C(109-179)  plasmid 
from the pETDuet1-Sec13/Nup145C (109-712) plasmid (kindly donated by S. Brohawn), for removal of 
parts  of  the  Sec13/Nup145C fusion  gene  coding  for  regions  of  Nup145C  that  were  not  part  of  the 
crystallization  construct.  Unlike  most  PCR  reactions  that  amplify  a  small  segment  of  a  large  DNA 
molecule, iPCR amplifies a majority of the plasmid, leaving out a small part of the sequence. The reaction 
mix for a 50 μl reaction is given in (table 1), the thermal cycling parameters are in (table 2). Primers used 
are in (table 3).
Component Volume
H2O 30.25 μl
DNTP mix (2mM each dNTP) 6.25 μl
Forward primer (5 μM) 2 μl
Reverse primer 2 μl
Vector DNA 4 μl
Pfu Buffer (10x) 5 μl
PfuUltra II Fusion HS DNA Polymerase 0.5 μl
Table 1. reaction mix for iPCR
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Temperature Time
95°C 2 min
Following steps repeated in 30 cycles:
95°C 20 sec
5°C less than the lowest melting temperature 20 sec
72°C 15 sec/kb-pairs of the vector
After 30 cycles, the reaction ends with following steps
72°C 3 min
4°C until the reaction is terminated
Forward primer 5'-GCTTTAGAGAAGAACTATTCG-3'
Reverse primer 5'-GATTTAATGAAGTGTACATATAAG-3'
After iPCR, remnants of PCR reagents were removed from the amplified DNA using the QIAquick PCR 
purification kit (Qiagen). 
The purified iPCR product was DpnI digested (50 μl of purified iPCR product, 5.7 μl NEB-buffer 
4 (10x), 1.3 μl DpnI) for 1h at 37°C. DpnI specifically recognizes a methylated restriction site. Since PCR 
products are not methylated, DpnI restriction ensured that the parental plasmid DNA would be degraded. 
The digest was again purified using the QIAquick PCR purification kit, but into 30 μl of elution buffer. 
Purified, DpnI digested iPCR product was than phosphorylated at 5' ends: 11.5 μl of iPCR product was 
mixed with 1.5 μl of T4 ligase buffer (10x) and 1 μl of T4 polynucleotide kinase and incubated for 1h at 
37°C. After 1h, 1 μl of T4 ligase was added to the mix. Ligation proceeded at room temperature overnight. 
After the incubation, E. coli DH5α cells were transformed with 5 μl of ligated vectors.
Table 2. Thermal cycling parameters for iPCR
C
Table 3. Primers used for iPCR of the Sec13/Nup145C fusion gene
C
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Site-directed mutagenesis
Plasmids  pETDuet1-Sec13(I12F)-Nup145C,  pETDuet1-Nup145C-Sec13(I12F),  pETDuet1-
Sec13(I12F)-Sec31(372-411)  and  pETDuet1-Sec31(1-748)-Sec13(I12F)  were  created  from pETDuet1-
Sec13-Nup145C, pETDuet1-Nup145C-Sec13, pETDuet1-Sec13-Sec31(372-411) and pETDuet1-Sec31(1-
748)-Sec13 plasmids via site-directed mutagenesis.  The PCR for mutagenesis was done following the 
protocol for iPCR (table 1)(table 2). Unlike primers for iPCR, forward and reverse primer pairs for site 
directed mutagenesis overlapped by several bases. The mutant base was located roughly in the center of 
the overlap (table 4).
Forward primer 5'-GAATTA  TTC  CATGACG  CTGTTCTAG-3'
Reverse primer 5'-CGTCATG  GAA  TAATTC  GTTGTGC-3'
PCR  products  were  analyzed  on  agarose  gels  and  PCR  purified  using  the  QIAquick  PCR 
purification kit, into 30 μl of elution buffer. The purified PCR products were than DpnI digested (30 μl 
purified PCR product, 3.5 μl NEB-buffer 4 (10x), 1.5 μl DpnI) for 1h at 37°C. After the incubation,  E.  
coli DH5α cells were transformed with 5 μl of DpnI digested vectors.  Since primers for site-directed 
mutagenesis  overlap, the PCR products had overlapping ends.  Therefore,  in vitro phosphorilation and 
ligation were unnecessary as E. coli enzymes performed the ligation reaction.
Table 4. Primers used for the Sec13 AA12Ile→Phe mutagenesis. Overlapping  
ends of the primers are underlined. The mutated codon  (ATC TTC) is in bold.C
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Genomic PCR
DNA fragments coding for Sec31(372-411) and Sec31(1-748) proteins were PCR amplified from 
S. cerevisiae genomic DNA (kindly donated by S. Brohawn). Two PCR runs were done: in the first run 
(table 5)(table 2), 
Component
H2O 33.75 μl
DNTP mix (2mM each dNTP) 6.25 μl
Forward primer (5 μM) 2 μl
Reverse primer 2 μl
Vector DNA 0.5 μl
Pfu Buffer (10x) 5 μl
PfuUltra II Fusion HS DNA Polymerase 0.5 μl
the DNA fragments were amplified directly from  S. cerevisiae genomic DNA. The PCR product was 
analyzed by agarose electrophoresis and purified using the QIAquick PCR purification kit. The resulting 
product, free of both remnants of S. cerevisiae DNA and of PCR reagents, was submitted to a second run 
of PCR (table 6)(table 7), optimized for amplification of sequences from smaller templates. Same primers 
were used for both runs. 
Component
H2O 33.25 μl
DNTP mix (2mM each dNTP) 6.25 μl
Forward primer (5 μM) 2 μl
Reverse primer 2 μl
Vector DNA 1 μl
Pfu Buffer (10x) 5 μl
PfuUltra II Fusion HS DNA Polymerase 0.5 μl
Table 5. reaction mix for the first round of genomic PCR
C
Table 6. reaction mix for the second round of genomic PCR
C
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Temperature Time
95°C 1 min
Following steps repeated in 30 cycles:
95°C 20 sec
5°C less than the lowest melting temperature 20 sec
72°C 30 sec/kb-pairs of the vector
After 30 cycles, the reaction ends with following steps
72°C 3 min
4°C until the reaction is terminated
The  primers  used  for  amplification  had  additional,  overhang  sequences  containing  sites 
recognized by restriction enzymes (table 8).
Sec31(372-411) forward primer 5'-GTGGTGTCCATATGCAAGCCCCAACTTGGTATG-3'
Sec31(372-411) reverse primer 5'-CCTGCTCTCGAGTCAGCCTGAAATTTTTGGGTTTGT 
TATAGATAC-3'
Sec31(1-748) forward primer 5'-ACCAGGATCCATGGTCAAACTTGCTG-3'
Sec31(1-748) reverse primer 5'-GCA AGG CGG CCG CTA ATG ATT TGC-3'
Table 7. Thermal cycling parameters for the second round of genomic PCR
Table 8. Primers used for amplification of sequences coding for Sec31(372-411) and Sec31(1-748). Recognition 
sites for NdeI (Sec31(372-411) forward primer), XhoI (Sec31(372-411) reverse primer), BamHI (Sec31(1-748) 
forward primer) and NotI (Sec31(1-748) reverse primer) are underlined.C
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Isolation of plasmid DNA
Plasmid DNA was isolated using the QIAprep spin miniprep kit, from E. coli DH5α grown in 5ml 
of medium with added ampicillin (0.1 mg ampicillin/ml) and incubated for ~7 h at 37°C with shaking (250 
rpm). DNA yield was estimated from absorbency at 260 nm, using the approximation
Cloning into the plasmid vectors
Plasmids  pETDuet1-Sec13-Sec31(372-411)  and  pETDuet1-Sec31(1-748)-Sec13  were  created 
from  plasmids  pETDuet1-Sec13-Nup145C  and  pETDuet1-Nup145C-Sec13  through  cloning.  The 
pETDuet1-Sec13-Nup145C  vector  and  genomic  PCR  product  Sec31(372-411)  were  digested  with 
restriction enzyme pair NdeI, XhoI. The pETDuet1-Nup145C-Sec13 vector and Sec31(1-748) insert were 
digested with the BamHI, NotI restriction enzyme pair. In both cases digestion of the vector removed a 
DNA fragment carrying the gene coding for Nup145C, leaving a place for Sec31 fragment insertion. The 
incubation time and volumes of substrate DNA were determined by total mass of the DNA (determined 
from A260) and by enzyme concentration (supplied by the manufacturer). Incubation temperature and the 
buffer used for double digest were determined according to instructions from the manufacturer. BSA was 
added to reaction mixtures; BSA reduces enzyme loss on tube and pipette tip surfaces, BSA has also been 
shown to stabilize enzymes in during reactions. The general reaction scheme is given in table 10.
Component Volume Final concentration
Vector/Insert DNA variable variable
Restriction enzyme 1 1 μl variable
Restriction enzyme 2 1 μl variable
BSA variable 100 μg ml-1
NEB buffer variable 1x
H2O variable \
The insert digestions were purified by QIAquick PCR purification kit into 30 μl of elution buffer. 
Loss of insert DNA was regarded as insignificant. Entire digested vector DNA was loaded onto an agarose 
γ(DNA)≈A
260
∙50 mg/ml
C
Table 9. The reaction scheme for restriction of DNA fragments
C
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gel. A band corresponding in size to a digested plasmid was excised and purified using the QIAquick Gel 
Extraction Kit. Concentration of purified plasmid was again determined from A260. Stoichiometry of the 
vector/insert DNA was calculated using the formula:
n(vector)/n(insert)= [γ(vector)/γ(insert)]∙ [l(insert)/l(vector)]
C
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The ligation reactions were always prepared by the scheme showed in table 11.
vector/insert 
ratio
3/1 1/1 1/3 Only vector (same volume as in 
3/1 vector/insert ratio
Final 
concentration of 
T4 ligase buffer
1x 1x 1x 1x
T4 ligase 1 μl 1 μl 1 μl 1 μl
H2O 0 μl 0 μl 0 μl Same volume as insert in 3/1 
vector/insert ratio
After a 2h incubation at room temperature, E. coli DH5α cells were transformed with 5 μl of each 
ligation mix.
Transformation of E. coli DH5α and BL21-RIL strains
For transformation, a 50 μl aliquot of E. coli DH5α cells would be thawed on ice. Than, 5 μl of 
DNA would be added to the aliquot and incubated on ice for 20 min. The bacteria would first be exposed 
to a 42°C heat-shock for 45s and than incubated on ice for another 2 min. Afterward, 300 μl of SOC 
medium (pre-warmed to 37°C) would be added to the bacteria which would than recover for 1h at 37°C 
with shaking (220 rpm). Recovered bacteria were evenly spread across LB-agar plates with 100 μg ml -1 
ampicillin. For transformation of E. coli BL21-RIL cells a modified protocol was used: first incubation on 
ice was shortened to 15 min and recovery was shortened to 30 min. Transformed cells were plated on LB-
agar plates with 100 μg ml-1  ampicillin and 30 μg ml-1 chloramphenicol. In both cases, inoculated plates 
were incubated at 37°C for a minimum of 12 h.
Table 10. The reaction scheme for ligation of restricted DNA fragments
C
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Electrophoresis on agarose gels
DNA samples were analyzed by agarose gel electrophoresis. In agarose gels, molecules of agarose 
interweave to  produce a  gel  of  hydrogen-bonded filaments.  Differences  in  macromolecular  migration 
through an agarose gel in an electric field are primarily a consequence of differences in size, shape and 
charge of molecules.  Since DNA molecules are mostly linear and have the same amount  of  negative 
charge  per  unit  of  mass  (due  to  the  repeating  orthophosphate  groups  within  the  molecule),  they are 
separated primarily by difference in size. Non-linearized plasmids are a notable exception, due to the 
effect of supercoiling on their shape.
Agarose gels were prepared by mixing agarose with TAE-buffer (40 mM Tris,  1 mM EDTA, 
titrated with concentrated hydrochloric acid to pH 8,0) and heating to ~100°C. When the agarose was fully 
melted in the TAE buffer, ethidium bromide was added to the mixture, gels were cast and left to cool 
down to room temperature. For analysis of DNA fragments coding for Sec31(372-411), 1.2% agarose gels 
were used. For all other procedures, 0.75% agarose gels were used. For analytical procedures, 1-5 μl of 
DNA sample was mixed with ~ 2 μl of loading buffer (2,5 % bromophenol blue, 10 mM EDTA pH 8,0, 3 
% glycerol, 2,5 % xylene cyanol) and loaded onto gels. Analytical electrophoresis were run in TAE buffer 
at 135 V for 15 min. For gel extraction procedures, 25 μl of restriction product would be mixed with ~5 μl 
of loading buffer and loaded onto the gel. Electrophoresis for gel extraction procedures were run in TAE 
buffer  at  100 V for 20 min.  Gels were analyzed  under UV light,  λ=314 nm,  which is  the excitation 
wavelength for ethidium bromide bound to DNA. The 1 kb DNA Ladder (NEB) and 100 bp DNA Ladder 
(NEB) were used for determination of DNA fragment sizes.
DNA primer synthesis and construct sequencing
DNA primers  were  ordered  from Integrated  DNA Technologies,  Coralville,  Iowa,  USA. 
Before use, primers were resuspended in water to a working concentration of 5 μM. Sequencing samples 
(5 μl plasmid DNA, 6 μl sequencing primer 5 μM , 11 μl H2O) were sent to the MGH DNA Core Facility, 
Cambridge, Massachusetts, USA, for sequencing. 
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Bacterial cultures
LB medium
LB (Lysogeny Broth) was used for growing all bacterial cultures:
 5 g/l yeast extract 
10 g/l tryptone
10 g/l NaCl
For LB-agar, 1.2% agar was added to the LB medium
Both the liquid LB medium and LB-agar were autoclaved prior to use.
Antibiotics for selective media: 100 μg ml-1 ampicillin 
30 μg ml-1 kanamycin
SOC medium
SOC (Supra Optimal broth with Catabolite repression) was used for transformed cell recovery:
2% w/v bacto-tryptone 
0.5% w/v bacto-yeast extract 
10mM NaCl 
2.5mMKCl 
Autoclaved
0.4% glucose
Storage of bacterial cultures
For long term storage, samples of overnight cultures were mixed with equal amounts of glycerol 
(40% w/v) and stored at -80°C.
27
Protein purification
Protein expression
For protein overexpression, sterile LB media with 100 μg ml-1 ampicillin, 30 μg ml-1 kanamycin 
and 0.4% glucose were  inoculated with a  ~7h old preculture  of  BL21-RIL cells  carrying  one of  the 
plasmids used in experiments. Cultures were grown at 30°C, 220 rpm, for ~3 h to an optical density of 
OD600≈ 0.6 before being transferred to 18°C, 220 rpm for 20 min. than, cells were induced with 200 μM of 
IPTG and left to grow over night at 18°C, 220 rpm. When grown to an optical density of OD600≈ 6, cells 
were pelleted by centrifugation (6 min, 6000g) and stored at -20°C until further processing.
Cell disruption
 Cells were resuspended in resuspension buffer (50 mM potassium phosphate buffer pH 8.0, 500 
mM NaCl, 20 mM imidazole, 3 mM BME) with stirring for a minimum of 20 min or until a homogeneous 
resuspension was obtained; 1 ml of resuspension buffer/100 OD600 (as determined before cell pelleting) 
was  added  to  the  pelleted  cells.  Cells  were  disrupted  using  a  French  press  cell  disrupter  (Constant 
Systems). Immediately after lysis, 0.2 mM of PMSF was added to the lysate to inhibit serine-proteases. 
The lysate was fractionated by centrifugation (20 min, 8000g). Supernatant was collected for further use. 
All steps were done at 4°C to prevent protein denaturation. 
Affinity chromatography on Ni-NTA agarose
Affinity chromatography is a group of methods for protein separation based on differential affinity 
of  proteins  for  binding  certain  molecules.  Affinity  chromatography on  Ni-NTA agarose  is  one  such 
method that exploits preferential binding of imidazole (or molecules carrying an imidazole group, e.g. 
histidine) to Ni2+ ions. The Ni-NTA beads are composed of agarose carrying nitrilotriacetic acid (NTA), a 
chelating  molecule  that  binds  four  out  of  six  coordination  bond  sites  on  a  nickel  Ni2+ cation.  The 
remaining two coordination sites are free to bind two histidine side chains from a His6-tag, covalently 
bound to a protein of interest. When the column is washed in buffer with a low concentration of imidazole 
(a low concentration of imidazole is usually present to prevent unspecific binding of non-tagged proteins 
to the beads), proteins without a His6-tag are washed away, while the tagged protein, together with any 
protein bound to it, remains attached to the Ni-NTA beads. The protein can than be eluted by washing the 
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Ni-NTA agarose in a buffer containing a high imidazole concentration. Imidazole competes with His6-tags 
for binding nickel cations, thereby releasing the protein of interest. Any protein bound to the His6-tagged 
protein will also co-elute in this step. Because the His6-tag has a small molecular mass and is not charged 
at pH 7.5-8.0, it usually has no effect on protein structure. In some constructs, the His6-tag is followed by 
a protease recognition motif and can be cleaved.
In this experiment, the Ni-NTA beads were first equilibrated with resuspension buffer  (50 mM 
potassium  phosphate  buffer  pH  8.0,  500  mM  NaCl,  20  mM  imidazole,  3  mM  BME).  Imidazole 
concentration in the resuspension buffer was too low to compete with His6-binding, but high enough to 
prevent most of the non-specific binding. BME prevented protein oxidation and formation of  disulfide 
bonds. The beads were mixed with the buffer and pelleted by centrifugation (3 min, 2000g). The process 
was repeated four times. The beads were than mixed with an equal volume of the resuspension buffer and 
added to the bacterial lysate supernatant. About 2 ml of Ni-NTA beads were added for each 1000 OD600/(L 
of bacterial culture). The supernatant-Ni-NTA mix was incubated for ~45 min, with stirring, at 4°C. After 
the incubation, nickel was collected by centrifugation (3 min, 2000g). The beads were washed three times 
by mixing with resuspension buffer and centrifugation (3 min, 2000g). After the last wash, beads were 
mixed with an equal amount of resuspension buffer and loaded onto a plastic column (Pierce). Another 
volume of resuspension buffer was added for wash. The proteins were eluted with elution buffer (50 mM 
HEPES buffer pH 7.4, 250 mM NaCl, 250 mM imidazole, 3 mM BME). All steps were done at 4°C to 
prevent protein denaturation.
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Dialysis and His6-tag cleavage
Dialysis  is  a  method  used  for selective  exchange  of  molecules  in  a  solution  based  on  the 
difference in their rates of diffusion through a porous membrane. The difference in diffusion rates is a 
consequence of molecular size: molecules that are smaller than the pores of the dialysis membrane, such 
as  small  molecules  and  ions,  can  transverse  the  membrane  freely  while  macromolecules,  being 
significantly larger than the pores in the dialysis membrane remain in the dialysis bag. 
Ni-NTA affinity purified protein samples were dialyzed in dialysis tubing (Thermo) to remove 
excess imidazole. Dialysis bags with the protein were put into 2L of dialysis buffer (20 mM HEPES buffer 
pH 7.4, 200 mM NaCl, 1 mM DTT, 0.1 mM EDTA) and left to stir overnight at 4°C. DTT in the buffer 
prevented protein oxidation and formation of disulfide bonds. EDTA is a chelating agent that inhibits 
protein degradation by binding potential cofactors for metalloproteases. 
An additional 200 μl of PrescissionProtease was added into the dialysis bag if the protein sample 
was intended for  crystallization experiments.  PrescissionProtease  is  a  fusion protein of  glutathione-S-
transferase (GST) and human rhinovirus (HRV) type  14 3C protease.  PrescissionProtease specifically 
recognizes the core amino-acid sequence Leu-Phe-Gln-Gly-Pro and cuts between glutamine and glycine 
residues.
Ion exchange chromatography
Ion exchange chromatography is a group of methods for protein separation based on different 
charges. The stationary phase contains charged molecules (usually having a carboxy group or an amino 
group conferring negative or positive charge respectively) termed ion exchangers that preferentially bind 
molecules depending on their overall charge. Proteins that have the opposite overall charge to that of the 
stationary phase will bind the ion exchangers, while other molecules flow through the column. Elution can 
be achieved by changing either the pH or the ionic strength of the chromatography buffer. If the pH is 
changed, proteins will be eluted from the column as they reach their pI. If the ionic strength is increased, 
proteins will release the ionic exchangers due to competitive binding of ions.
PrescissionProtease  was  removed  from  the  dialyzed  protein  solution  by  ion-exchange 
chromatography on  HiTrap™ IEX SP Fast  Flow columns  (GE Healthcare).  Before  chromatography, 
columns were equilibrated with washing buffer  (20 mM HEPES buffer pH 7.4, 1 mM DTT, 0.1 mM 
EDTA). After equilibration, samples were run through the column. The weakly charged sample protein 
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would be collected in the flow through while the more strongly bound His6-tags would elute from the 
column with rising ionic strength, i.e. by gradually mixing the washing buffer flowing through the column 
with an increasing percentage of ion exchange elution buffer (20 mM HEPES buffer pH 7.4, 1 mM  DTT, 
0.1 mM EDTA, 2 M NaCl).
Gel filtration chromatography
Gel  filtration  chromatography is  a  method  for  separating  molecules  based  primarily  on  their 
hydrodynamic  volume.  The stationary phase of  the  column is  composed  of  small  beads  of  different, 
chemically inert,  polymers  containing pores of different sizes. As various molecules flow through the 
column, smaller ones fit into the pores and flow slowly while larger molecules cannot fit into the pores 
and move through the column more quickly. The pore size is specified for a given column, but is far from 
exact. In columns with larger pores, molecules will move more slowly than in columns with smaller pores. 
For  purification  of  the  Sec13/Nup145C(109-179)  fusion  construct  and  analysis  of  Sec13-
Sec31(372-411) and Sec13(I12F)-Sec31(372-411) binding,  HiLoad 26/60 Superdex 75pg columns (GE 
Healthcare) were used. For analysis of Sec13-Nup145C, Sec13(I12F)-Nup145C, Sec13-Sec31(1-748) and 
Sec13(I12F)-Sec31(1-748) binding HiLoad 26/60 Superdex 200 pg columns (GE Healthcare) were used. 
Fractions containing protein were analyzed by SDS PAGE and pooled together. Due to the variability in 
pore size and inherent flexibility of protein shape, the samples did not elute in sharp, narrow concentration 
peaks  but  rather  in  Gaussian  shaped  concentration  curves  covering  several  fractions.  To  reduce  the 
possibility of sample contamination with misfolded proteins, fractions at the edges of concentration peaks 
were not pooled with the rest of the protein in samples intended for crystallization experiments.
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Protein concentration determination
Protein concentration was determined by UV-spectrophotometry from absorbency at λ= 280 nm. 
Extinction coefficients for different proteins were calculated using ProtParam (Expasy) (table 11)
Protein sample Abs 0.1% (=1 g/l)
Sec13/Nup145C(109-179) 2.11
Sec13 (with His6 tag) 2.56
Sec13 (without His6 tag) 2.81
Nup145C 1.01
Sec31(372-411) 1.64
Sec31(1-748) 1.30
SDS PAGE
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) is a method for protein 
separation in an electric field based on their molecular weight.  A polyacrylamide gel is  formed by a 
network of polyacrylamide molecules interconnected by N,N'-methylenebisacrylamide linkers. Pore size 
of a polyacrylamide gel is constant and is defined bya ratio of concentration of acrylamide molecules to 
the concentration of N,N'-methylenebisacrylamide molecules. SDS is an anionic detergent that denatures 
proteins by inserting its hydrocarbon tail into the hydrophobic interior of the protein while conferring a 
uniform, negative charge to the surface of the protein. Since all proteins in an SDS PAGE sample have 
equivalent  shapes (spherical  denatured globules)  and mass/charge ratios (approximately 1.4 g of SDS 
binds 1g of protein with very little dependence on the protein type), differences in migration of proteins 
within the gel are mostly a consequence of the difference in molecular weight. When a proper molecular 
weight marker is used and a solution that is analyzed is relatively pure, SDS PAGE can serve as a semi-
quantitative method for identification of proteins. In SDS PAGE, two gel types are used: a stacking gel 
that  stacks  all  the  macromolecules  from a  solution  into  a  single,  narrow band  and  a  separating  gel 
(positioned underneath the stacking gel), that separates this narrow band into separate bands based on 
molecular weight of component proteins.
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In this experiment samples for SDS PAGE were prepared by mixing 5 μl of protein sample with 2 
μl of sample buffer (50 mM Tris-HCl pH 6,8, 1 % (w/v) SDS, 5 mM BME, 5 % glycerol, 0,02 % BPB) 
and heated to 96°C for ~5 min. Alternatively, for visualization of lower concentrations of proteins, 20 μl 
of protein sample was mixed with 5 μl of sample buffer and heated to 96°C for ~5 min. The pellet from 
the fractionation of the cell lysate was resuspended in 20 ml of urea and homogenized using a Dounce 
homogenizer before taking samples for the electrophoresis.
Two types of separating gels were used; 10 % acrylamide gels (table 12) were used for analyzing 
all  protein  samples,  additionally,  16.5%  acrylamide  gels  (table  12)  were  used  for  analyzing  Sec13-
Sec31(372-411) and Sec13(I12F)-Sec31(372-411) complexes. In both cases, the gels were poured into 
Mini PROTEAN III Electrophoresis Cell  casts (BioRad) and overlaid with isopropyl alcohol. When the 
separating gel hardened, stacking gel (table 12) was poured over it.
Separation gels Stacking gels
10% 16.5% 5.3%
30% acrylamide/bisacrylamide 13.33 ml 22 ml 1.77 ml
Separating buffer 10 ml 10 ml 0 ml
Stacking buffer 0 ml 0 ml 2.5 ml
H2O To 40 ml To 40 ml To 10 ml
10% APS 400 μl 400 μl 100 μl
TEMED 40 μl 40 μl 10 μl
Electrophoresis were run at 200 mV for 10 min followed by 250 mV for 35 min. Gels were fixed 
in a fixing solution (25% isopropyl alcohol, 10% acetic acid) for ~10 min before staining with staining 
solution (10% acetic acid, 100 mg/l Coomassie Brilliant Blue R250) for ~2 days. Gels were destained in 
10% acetic acid for ~2 days before photographs were taken. The  Protein Marker, Broad Range (2-212 
kDa) (NEB) was used for determination of DNA fragment sizes.
Table 12. compositions of SDS PAGE gels
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Solution of the protein crystal structure
To determine the crystal structure of the Sec13/Nup145C(109-712) protein complex, crystals of 
the purified construct were obtained. Diffraction data was collected and an electron density map was 
calculated. After structural refinement, the protein structure was analyzed.
Crystal growth
Proteins  are  usually  dissolved  in  an 
unsaturated solution containing water, buffer and 
salts. In an unsaturated solution, no crystals will 
nucleate, nor will crystals grow from preexisting 
seeds.  In  a  crystallization  experiment,  a 
precipitant is added to the protein solution. The 
precipitant decreases the solubility of the protein, 
thereby increasing the saturation of the mixture. 
Depending on the level of saturation, four zones 
of crystal growth can be defined (Figure 7). In the 
stable  zone,  the  solution  is  still  unsaturated,  as 
before  the  experiment.  In  the  metastable  zone, 
preexisting crystallization seeds will grow, but no 
new nucleation of crystals will occur. In the labile 
zone spontaneous crystal nucleation and growth happen. In the precipitation zone, the protein becomes 
completely insoluble and precipitates from the solution.
There are several approaches for setting a crystallization experiment. In vapor diffusion methods, 
a  droplet  containing the  protein solution  with added precipitant  is  placed in  a  closed  system with  a 
reservoir  of  pure precipitant.  As the concentration of precipitant  increases through diffusion from the 
reservoir, solubility of the protein gradually decreases.
A common method for executing vapor diffusion experiments is a hanging drop method in which 
a droplet containing the protein solution is suspended over a reservoir of the precipitant.
When crystals  grown in the labile zone are not  useful  for  structure determination,  one of the 
approaches  available  is  microseeding.  In  a  microseeding  experiment,  a  crystal  is  pulverized  into 
Figure 7. Four zones of crystal growth: A  stable zone, B  limit of 
solubility, when the solid and liquid phase of the protein are in 
equilibrium, C   metastable zone, D  labile zone, E  precipitation zone 
(Bergfors, 2003) C
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submicrometer sized fragments. These fragments are than transferred into a protein solution that is in the 
metastable zone, where they serve as seeds for crystal growth. Since no nucleation sites can spontaneously 
occur in a metastable solution, the number of crystals that can grow in such an experiment is limited by 
the number of seeds introduced. If the number of seeds is small enough, only a few crystals will grow. 
With less competition for dissolved protein, crystals can grow larger and in a more regular fashion. Since 
nucleation seeds are invisible, making determination of the exact amount of the seeds that are introduced 
into a solution impossible, a dilution series is made. In addition to seeding, there are numerous techniques 
for  crystal  quality  improvement.  Despite  developments  in  understanding  the  process  of  protein 
crystallization, finding a proper condition for crystallization remains a trial and error process. Automated 
systems  for  setting crystallization experiments  using commercially available  screens  make  identifying 
initial conditions for crystal growth a much faster and less labor intense task.
 In this experiment, initial crystals were grown by the hanging drop vapor diffusion method. A 0.5 
μl drop of protein (γ= 85.3 mg ml-1) was mixed with 0.5 μl of precipitant (26.5 % PEG 4K, 0.25 M LiCl, 
0.1 M Tris pH 8.3). Crystals were grown at 16°C, over a reservoir containing 400 μl of precipitant. After 
three days, the crystals were prepared for microseeding using the Seed Bead (Hampton) seeding kit. The 
precipitant solution served as a stabilizing solution for the seeds. A series of dilutions (100-107) of the seed 
stock was made.
In a repeated crystallization experiment, 0.5 μl of different precipitant solutions (26.5 %-25% PEG 
4K, 0.25 M LiCl, 0.1 M Tris pH 8.3) and 0.2 μl of seed dilutions were added to 0.5 μl drops of protein (γ= 
85.3 mg ml-1). Crystals were grown at 16°C, over reservoirs containing 400 μl of precipitant. Crystals 
from this experiment (grown over a precipitant containing 26% PEG 4K, 0.25 M LiCl, 0.1 M Tris pH 8.3) 
were used in a second round of seeding. The crystal used for obtaining the structural data was grown for 
three days from protein concentration (γ= 37.9 mg ml-1), at 16°C using a precipitant solution containing 
22% PEG 4K, 0.25 M LiCl, 0.1 M Tris pH 8.3. The crystal was collected using a nylon loop, dipped into 
25% glycerol for cryopreservation and stored under liquid nitrogen.
Data collection
Diffraction  data  was  collected  by  S.  Brohawn  and  T.  Schwartz  at  the  Argonne  National 
Laboratory Advanced Photon Source synchrotron facility, DuPage County, Illinois, USA, at the beamline 
24-ID-C, operated by the Northeastern Collaborative Access Team ( NE-CAT). 
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 Structure determination and refinement
Diffraction data was processed using the HKL-2000 software package. Phases were solved using 
the CCP4i software package. PDB file 2pm6 was used as a template for molecular  replacement.  The 
electron density map was refined using the phenix.refine program package. Manual refinement was done 
using Coot and phenix.refine.
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Tools for protein structure visualization and sequence analysis 
Protein  structures  were  visualized  in  PyMol  and  Coot.  Sequencing  results  were  evaluated  in 
MacVector.  EnzymeX  was  used  for  primer  design  and  protein  and  DNA sequence  analysis.  Protein 
complexes observed in crystal structures were evaluated using PISA (EBI). Protein sequence conservation 
was  analyzed  by  T-Coffee  (EBI).  Sequences  of  Nup145C  from  Saccharomyces  cerevisiae, 
Vanderwaltozyma polyspora, Homo sapiens and of Sec13 from Drosophila melanogaster, Aedes aegypti, 
Neurospora crassa,  Arabidopsis thaliana,  Homo sapiens and  Saccharomyces cerevisiae were obtained 
from the SwissProt database using Blast (NCBI) and SRS (EBI).
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Results
Production of the crystallization construct
The  Sec13/Nup145C(109-179)  fusion  construct  that  was  used  for  crystallographic 
experiments was produced through iPCR. Success of PCR amplification was judged from agarose 
gel electrophoresis (Figure 8). The amplified sequence was further verified by DNA sequencing. 
The construct is composed of an amino-terminal His6-tag followed by a full length yeast Sec13 
protein and a carboxy-terminal insertion blade consisting of yeast Nup 145C amino acids 109 to 
179. The His6-tag is separated from Sec13 by a PrescissionProtease site. Sec13 is separated from 
the carboxy-terminal domain by an amino acid linker.
Figure 8. Result of iPCR production of 
the Sec13/Nup145C(109-179) fusion 
construct. Lane 1 is the DNA ladder. The 
band ~6 kb visible in lane 2 belongs to 
iPCR amplified construct and vector
10  kb
8  kb
6  kb
5  kb
4  kb
3  kb
2  kb
1  kb
1.5  kb
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Expression and purification of the crystallization construct
The Sec13/Nup145C(109-179) fusion protein was expressed in BL21-RIL cells. Induction 
of construct protein expression was successful. Majority of the protein was soluble in the lysis 
buffer.  The fusion protein  was purified via  affinity  purification  on Ni-NTA agarose.  Several 
contaminants were present in the eluate (Figure 9). The His6-tag was removed from the protein by 
PrescissionProtease cutting and subsequent ion exchange chromatography.
Remaining  contaminants  were  removed  by  gel  filtration  chromatography  (Figure  10). 
Protein-rich  fractions  were  chosen  from  A280 data  and  analyzed  by  SDS  PAGE.  Fractions 
containing the Sec13/Nup145C(109-179) fusion protein were identified by protein size, as judged 
from  gel  filtration  chromatograms  and  SDS  PAGE.  These  fractions  were  pooled  and 
concentrated.  Edge  fractions  of  the  peaks  were  left  out  of  the  pools  to  eliminate  possible 
perturbations that cause the protein to travel on a gel filtration column differently from the most 
of the sample (Roe, 2001).
The  pooled,  concentrated  protein  samples  were  immediately  used  in  crystallographic 
experiments  as  one  day  old  samples  produced  crystals  of  significantly  lower  morphological 
quality (smaller, thinner, more irregular crystals, as judged from visual observation). 
Figure 9. SDS PAGE of fractions from purification of the 
Sec13/Nup145C(109-179) fusion protein on NiNTA agarose. From left 
to right: marker, soluble fraction of the cell lysate, insoluble fraction of 
the cell lysate, column flow-trough, wash, elution. The construct forms 
the ~55 kDa band. Other bands belong to contaminants.
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
Figure 10. Gel filtration chromatogram of the 
Sec13/Nup145C(109-179) fusion protein. Fractions B1-B6 
were pooled and concentrated for crystallographic experiments. 
A
280
 is in blue.
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Crystallization experiments
Initial crystals were grown in the 'sitting drop' arrangement, from two kinds of solutions, 
both part of the commercially available PEGs II Suite (Qiagen) crystallization condition screen:
• A combination of plate-like crystals and proteinaceous spherulites grew at 16°C in a mix 
of 0.15 μL of an aqueous solution of 0.2 M Sodium acetate, 0.1 M Tris pH 8.5 and 30% 
PEG 4000 with an equal volume of the purified Sec13/Nup145C(109-179) fusion protein 
construct (γ = 8.8 mg mL-1).
• Plate-like crystals grew at 16°C, in a mix of 0.15 μL of an aqueous solution of 0.1 M 
Lithium chloride, 0.1 M Tris pH 8.5 and 28% PEG 6000 with an equal volume of the 
purified Sec13/Nup145C(109-179) fusion protein construct (γ = 8.8 mg mL-1). 
The initial crystallization conditions were successfully reproduced in the 'hanging drop' 
arrangement, with 2 μL and 1 μL drops.
Crystals  used  for  structure  determination  were  grown  in  1μL  drops,  from  protein 
concentration (γ = 37.9 mg mL-1), at 16°C , with a precipitant solution containing 22% PEG 4K, 
0.25 mol dm-3 LiCl, 0.1 mol dm-3 Tris pH 8.3. A seeding procedure was used. These crystals were 
soaked  in  cryoprotectants  and  frozen  in  liquid  nitrogen.  A  crystal  soaked  in  25%  glycerol 
provided highest quality data.
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Molecular structure determination
Phase determination and structural refinement
A data set of diffraction maxima of down to 2.45 Å resolution was obtained. The space 
group of the crystal was determined to be P21212. A previously known structure, accessible in the 
protein data  bank under  code 2pm6,  was  used for  molecular  replacement.  The structure was 
refined to Rworking/Rfree values of 23%/28%. Crystal lattice properties and refinement statistics are 
summarized in table 13.
Crystal properties
Space group P 21 21 2
a, b, c 68.2Å, 93.8Å, 55.0Å
α, β, γ 90.00°, 90.00°, 90.00°
Data collection
Resolution 50.00-2.45Å
Completeness 94.2%
Refinement
Resolution 29-2.45Å
No.  of  unique 
reflections
12,723
Rworking/Rfree 23.4%/28.4%
No. of atoms
Protein
Water
2575
2557
18
Wilson B-factor (Å2) 63.37
r.m.s.d.
Bond lengths (Å)
Bond angles (deg)
0.003
0.701
Table 13. Lattice properties, data set statistics and refinment results.
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Overall structure
A single molecule is present in the asymmetric unit. There are several contacts between 
molecules in adjoining cells (Figure 11). These contacts are presumed to be the reason behind 
relatively quick formation of crystals (fully-grown crystals were obtained one day after starting 
crystallographic experiments). 
The molecule is an overall donut-shaped structure (height ~40Å, diameter ~70Å), with a 
central  cavity  (diameter  ~15  Å)  extending  roughly  halfway  down the  axes  of  the  structure, 
followed by a water-filled central cavern. The opposite end of the molecule is indented toward 
B)
Figure 11. Contacts between  neighboring molecules in the Sec13/Nup145C(109-179) crystal. A) Loop connecting Nup145C β-strands 2-3 
(violet) binding loop connecting Sec13 β-strands 8-9(green).   B) A close-up of A)
A)
A) B)
Figure 12. General shape of the Sec13-Nup145C (109-179) complex. A) Side view  B) Top view. Sec13 is yellow, Nup145C is violet.
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the  central  cavern.  The  six  amino  terminal  residues  of  Sec13  protrude  from  the  donut-like 
structure,  perpendicularly  to  the  axes.  The  four  amino-acids  preceding  the  amino-terminal 
methionine are linkers to the (removed) His6-tag and are not a part of wild-type Sec13 in yeast. 
Another protrusion from the structure is formed by the amino-terminal α-helix of the Nup145C 
insertion blade. The α-helix protrudes from the molecule on the opposite side to the cavity, under 
a ~45° angle to the shorter axes (Figure 12). 
The secondary structure of the molecule consists predominantly of β-strands, which form 
a fold that has been termed the seven bladed β-propeller  (Berke et al., 2004). The six blades of 
this fold are each formed by four antiparallel β-strands of Sec13 (numbered 1-24, starting from 
the amino-terminus). The strands are connected in a β-meander-type supersecondary structure. 
The last β-strand of each meander is connected to the first β-strand of the next one by a loop. A 
seventh blade is formed by three antiparallel β-strands of the carboxy-terminal segment of the 
Nup145C insertion blade. This blade also assumes a β-meander-type supersecondary structure. 
The only extensive α-helical region is the amino-terminus of the Nup145C insertion blade. The 
amino-terminal α-helix and the carboxy-terminal β-strand of the Nup145C insertion blade are 
connected by a nine amino-acid long extended region lacking a defined secondary structure. The 
two faces of the donut-shaped structure are covered by loops and three short, α-helical regions. 
Several  features are notably absent from the structure.  The nine amino-acid long loop 
linking the carboxy-terminus of Sec13 to the amino-terminus of the Nup145C insertion blade 
shows no density and, thus, could not be modeled into the structure. A five amino-acid long 
segment between Phe130 and Thr136 (between β-strands 11 and 12) and an eight amino-acid long 
segment between Tyr157 and Gly166 (between β-strands 13 and 14) of Sec13 are also absent from 
the electron density map. Since these regions are located between β-strands, they probably form 
highly mobile loops.
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Surface properties, structural flexibility and sequence conservation
The surface of Sec13 bound to  the Nup145C insertion blade features  several  charged 
regions. A negatively charged surface is formed by Sec13 amino acids Glu250, Glu251, Glu286 and 
peptide carbonyl oxygen atoms from Sec13 amino acids Leu248, Gly287 and Trp289. These amino 
acids are parts of loops connecting β-strands 20-21 (belonging to the fifth and the sixth blade of 
the Sec13 six-bladed β-propeller) and 23-24 (within the sixth blade). The amino-terminal α-helix 
of  the  Nup145C insertion  blade  is  positively  charged.  Sec13 amino  acids  Lys244,  Lys245 and 
peptide amino groups from Sec13 amino acids Thr235, Gln236 and Thr246 form a positively charged 
patch on β-strands 19 and 20 (fifth blade of the Sec13 six-bladed β-propeller). Similarly, Sec13 
amino acids His43 and Lys44, together with the peptide amino group of Sec13 amino acid Thr42 (β-
strand 4) join the Nup145C amino acid Lys167 (part of the loop connecting Nup145C β-strands 2-
3) in forming another positively charged patch. 
The temperature factor, also called the B-factor, is a measure of the dynamic order in the 
crystal,  caused by temperature-dependent  vibration  of  the  atoms  within the  molecules  of  the 
crystal. The B-factor is given in Å2 and is proportional to structural flexibility (Drenth, 2007). 
Within the structure of the Sec13/Nup145C(109-179) fusion protein construct, observation of the 
B-factors for different regions of the molecule indicates that the central region of the β-propeller 
is fairly rigid, while the loops above and below the propeller are flexible. The β-strands that are in 
B)A)
Figure 13. Flexibility of the Sec13-Nup145C (109-179) complex. Thicker amino acid chain indicates higher B-factor and, therefore, higher 
flexibility. A) Side view. B) Top view.
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contact with the solvent (generally the fourth β-strand of each blade) are more flexible than the 
strands that are buried deeper within the protein. Several segments of the protein are especially 
flexible, notably the amino-terminal α-helix of the Nup145C insertion blade and loops connecting 
β-strands 17-18, 19-20 and the visible parts of loops connecting β-strands 11-12 and 13-14. These 
loops are all located on the same side of Sec13 and probably face the carboxy-terminal domain of 
Nup145C  in  yeast.  Loops  that  are  located  proximally  to  the  amino-terminal  α-helix  of  the 
Nup145C insertion blade are as rigid as the interior regions of the protein (Figure 13). 
Plotting  Sec13 sequence  conservation  on the  Sec13/Nup145C(109-179)  fusion  protein 
structure  revealed  that  the  inner  parts  of  the  protein  are  more  conserved  than  the  solvent-
contacting regions. Indeed, in all six blades, the outer β-strands (i.e. strands 4, 8, 12, 16, 20, 24) 
have few or no conserved amino acids, while the inner strands are conserved either fully or in 
most of their length. The only inner β-strands to have more than one non-conserved amino acid 
are strands 1 and 5 that have two non-conserved amino acids each. A significant part of these two 
strands (including the non-conserved amino acids) is in contact with the solvent in the central 
cavity. Loops connecting the β-strands show varying degrees of conservation. In general, loops 
proximal to the axes of the molecule tend to be better conserved than the distal loops.
Figure 14. Conservation of the Sec13 and Nup145C insertion blade sequences. 
Conserved regions are red. Non-conserved regions are green for Sec13 and 
cyan for Nup145C. Partially conserved residues are yellow.
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Since the parts of the protein that are in proximity to solvent tend to be variable across 
phyla,  general  surface  conservation  is  low.  Large,  conserved  areas  are  generally  those 
surrounding the Nup145C insertion blade, the surface facing the amino-terminal α-helix of the 
Nup145C insertion blade and the surface lining the entrance into the central cavity. A conserved 
patch is formed by loops connecting β-strands 1-2 and 5-6.
Overall, amino acid sequence of the Nup145C insertion blade is far less conserved across 
phyla than that of Sec13. Here too, the best conserved segment of the sequence forms the inner-
most β-strand (strand 1), while the sequence of the outer β-strand (strand 3) is not conserved and 
has insertions in other species. The sequence of the amino terminal α-helix is not well conserved, 
although it  lacks  insertion  mutations  between species.  Amino  acids  Arg142 and  Arg143 of  the 
amino terminal region are conserved between humans and yeast (Figure 14). 
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Protein binding interface
The Nup145C-Sec13 interface covers an area of 1869.5 Å2 (calculated by PISA). Two salt 
bridges  and 27  hydrogen  bonds  are  predicted  by PISA to  be  responsible  for  protein-protein 
interactions.  Most  of  the  hydrogen  bonds  are  main-chain/side  chain  interactions.  Several 
structurally bound water molecules are also visible in the interface, making hydrogen bonds to 
residues from both Nup145C and Sec13. An extensive network of hydrogen bonds is formed by a 
water molecule bound to Sec13 amino acids Asp18 and Tyr19 and Nup145C amino acids Ser154 and 
Thr155.
Starting from the amino terminus of the Nup145C fragment, the first amino acid to make 
contact with Sec13 is Ile138, whose side chain is immersed into a hydrophobic pocket formed by 
side chains of Sec13 amino acids Pro55 and Tyr75. Sec13 Tyr75 side chain is also hydrogen-bonded 
to Nup145C Glu141. Both Ile138 and Glu141 are part of the Nup145C amino-terminal α-helix. 
Figure 15. Contacts between Sec13 and Nup145C. A) Nup145C amino acid  Ile138, whose contacting sidechains of Sec13 amino acids Pro55
and Tyr75.  Sec13 Tyr75 side chain is hydrogen-bonded to Nup145C Glu141. B) A salt bridge between the Nup145C amino acid Arg143 forms 
and Sec13 amino acid Asp205. C) Nup145C amino acids Phe144, Tyr148 and Phe150 binding side chains of Sec13 amino acids Ile12, His13, Ala15, 
Trp57 and Trp258. D) Nup145C amino acid Phe153 binding Sec13 amino acids Val268, Ala270 and Leu280. Sec13 is orange, Nup145C is violet.
A) B)
C)
D)
47
Further downstream, the region linking the α-helical segment to the insertion blade of the 
Nup145C fragment  is  attached  to  Sec13  by  a  combination  of  salt  bridges  and  hydrophobic 
interactions.  The  Nup145C  amino  acid  Arg143 forms  a  salt  bridge  to  Sec13  Asp205.  Three 
Nup145C amino acids, Phe144, Tyr148 and Phe150 immerse their large, aromatic side chains into a 
hydrophobic environment created by side chains of Sec13 amino acids Ile12, His13, Ala15, Trp57 
and Trp258
In the Nup145C insertion blade, Phe153 (part of β-strand 1) is immersed into a hydrophobic 
pocket created by Val268, Ala270 and Leu280 of the sixth blade of the Sec13 β-propeller. On the 
opposite face of the same β-strand, Lys152 forms a salt bridge to Asp14 of the Sec13 first blade. 
Nup145C β-strands 2 and 3 are bound to the first and sixth β-propeller strands of Sec13 through 
hydrophobic interactions involving aliphatic side chains (Figure 15). 
Comparison to known structures of Sec13
Previously solved structures of Sec13 include two structures of ySec13 in complex with 
ySec31  (Fath et al., 2007) and a structure of hSec13 in complex with yNup145C  (Hsia et al., 
2007). Additionally, a structure of yeast Sec13 paralog Seh1 bound to yNup85 has been solved 
(Brohawn et al., 2008) (Figure 16). Comparison of these structures to the structure of ySec13 in 
complex with a fragment of yNup145C revealed conserved features. 
Structures of  Sec13 bound to the amino terminal β-propeller and the carboxy-terminal 
domains of Sec31 reveal that Sec13 bound to the Sec31 insertion blade has the same overall 
shape as the Sec13/Nup145C construct. Some of the more notable differences are the absence of 
β-strand 20 (this segment of Sec13 lacks a defined secondary structure in Sec13/Sec31 structures) 
and a shorter β-strand 19 in the blade 5 of Sec13 bound to Sec31. Unlike the Sec13/Nup145C 
construct structure, the loop connecting β-strands 11-12 is clearly present, although with a high 
B-factor, indicating flexibility. Like in the Sec13/Nup145C structure, a large segment of the loop 
connecting β-strands 13-14 could not be modeled into the structure.  All of these features are 
present in both structures of Sec13 bound to Sec31. The β-strand 24 that is completely absent in 
the structure of Sec13 bound to the amino terminal β-propeller domain of Sec31 and is very short 
in the structure of Sec13 bound to the carboxy-terminal domain of Sec31 is much longer in the 
Sec13/Nup145C structure.
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Examination of the Sec13-Sec31 interaction interface reveals that the region linking the 
amino-terminal  β-propeller  domain  to  the  insertion  blade  of  Sec31  is  attached  to  Sec13  by 
hydrophobic contacts that are arranged in a different manner than those in the Sec13-Nup145C 
complex. Tyr377 of Sec31 is inserted into a hydrophobic pocket formed by Sec13 amino acids 
Trp57 and Tyr75. Sec13 amino acid Trp206 side chain is too far away from the interaction site to 
make contact with the insertion fragment of Sec31. The side chains of Sec13 amino acids Trp258 
and His13 interact with Sec31 amino acids Gly378 and Pro280.
The first β-strand of the Sec31 insertion blade is bound to the sixth blade of the Sec13 β-
propeller through two hydrogen bonds that Sec31 Trp386 makes with Sec13 Ser261 and through 
hydrophobic contacts between Sec31 Trp386 and Val268, Ala270 and Leu280 of the sixth blade of 
Sec13.  The  second  and  the  third  insertion  blade  of  Sec31  bind  Sec13  through  nonspecific 
contacts between aliphatic amino acid side chains.
Analysis  of  structures  of  Sec13  bound  to  Sec31  in  PISA  revealed  several  ionic 
interactions.  Two  salt  bridges  are  observed  in  the  combined  structures  of  the  Sec13-Sec31 
interactions. Sec13 Asp14 is bound Sec31 His385 and Sec13 Asp205 is bound to Sec31 Lys19. An 
additional salt bridge is visible in the structure of Sec13 bound to the amino terminal β-propeller 
of Sec31: here, Sec13 Arg259 is coupled to Sec31 Glu379. In the structure of Sec13 bound to the 
carboxy terminal domain of Sec31, the side chain of Sec13 Arg259 assumes a different rotamer 
and protrudes into the solvent.
Figure 16. Structures of Sec13 bound to domains of Sec31. A) Sec13 (yellow) bound to the carboxy terminal domain  of Sec31 (purple).  B) 
Sec13 (violet) bound to the amino terminal domain  of Sec31 (orange).  C) Structure oft he human Sec13-yeast Nup145C hybrid. Sec13 is 
orange,  Nup145C is violet D) Structure of yeast Nup85-Seh1 complex. Sec13 is purple, Nup85 is yellow
A)
B) C) D)
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Structure of the human Sec13/yeast  Nup145C hybrid,  again, displays  the same overall 
donut-shaped structure as the yeast  Sec13-Nup145C construct.  A notable difference is the far 
lesser degree of secondary structure in the third and the fourth blade of the human Sec13 six 
bladed β-propeller: β-strand 16 spans four amino acids, β-strands 12 and 15 are composed of 
three amino acids each, while β-strands 13 and 14 consist of one amino acid each. In yeast Sec13 
strands 16 and 15 span 9 amino acids, strand 14 spans 6, strand 13 spans 5 amino acids, while 
strand 12 consists of 4 amino acids. 
A part  of the loop spanning human Sec13 amino acids Trp158 to Phe182,  connecting β-
strands 13 and 14 (corresponding to the yeast Sec13 loop spanning amino acids Trp153 to Lys172) 
is missing from the structure, similarly to yeast Sec13. Compared to the yeast Sec13 loop 13-14, 
the loop in human Sec13 is five amino acids longer. Initial four amino acids of the loops are fully 
conserved between human and yeast. 
Overlay of yeast  Sec13 and Seh1 structures reveals  significant structural  conservation. 
Overall features of a six-bladed β-propeller are conserved in Seh1. The region corresponding to 
β-strand 1 in Sec13 does not assume a defined secondary structure in Seh1. Compared to yeast 
Sec13, β-strands of the third blade of Seh1 are shorter. The loop connecting β-strands 12 and 13 
(corresponding to strands 13 and 14 in Sec13) is partially absent from the structure of Seh1.
Amino acid contacts in the Seh1-Nup85 interaction sites do not appear to be conserved 
between yeast  Sec13 and Seh1. The area corresponding to the first  β-strand of the Nup145C 
insertion blade does not assume a defined secondary structure in Nup85.
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Amplification  of  Sec31  constructs  and  site-directed  in  vitro 
mutagenesis of Sec13
Based on  the  comparison  of  the  crystal  structure  obtained  in  this  project  (ySec13  in 
complex  with  yNup145C)  to  known  structures  of  the  ySec13-ySec31  complex,  a  Sec13 
(AA12I→F) mutant  was designed.  The Sec13 (AA12I→F)  mutation was hypothesized to disrupt 
ySec13-yNup145C binding without affecting ySec13-ySec31 binding. This mutant was produced 
through site-directed in vitro mutagenesis. The gene coding for ySec13 was part of a bicistronic 
pETDuet-1 plasmid vector. The other available expression cassette contained a gene coding for 
either Nup145C or a fragment of Sec31. Due to difficulties in PCR amplification of full length 
ySec31, the Sec311-748 and Sec31372-411 fragments were PCR-amplified from yeast genomic DNA 
and cloned into the plasmid vector. Results of PCR amplifications were judged from agarose gel 
electrophoresis. Construct sequences were verified by DNA sequencing.
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Coexpression  and  copurification  of  protein  Sec13  with 
Nup145C, Sec311-748 and Sec31372-411
 To  confirm  the  hypothesis  that  the  Sec13  (AA12I→F)  mutation  selectively  disrupts 
ySec13-yNup145C binding, either wild type Sec13 or Sec13 (AA12I→F) were coexpressed with 
full length Nup145C, Sec31372-411 (Sec31 amino acids 372-411) or with Sec311-748 (Sec31 amino 
acids 1-748). Binding efficiency was judged from protein copurification on Ni-NTA agarose and 
from gel filtration chromatography.
For protein copurification on Ni-NTA agarose, the His6-tag was attached to the Sec13 
amino terminus in Sec13-Sec31372-411 copurifications and to the Sec31 amino terminus in Sec13-
Sec311-748 copurifications. In Sec13-Nup145C copurifications, two different arrangements were 
used, with the His6-tag attached to either the Sec13 or Nup145C amino termini.
Induction
Induction  efficiency  was  judged  from SDS  PAGE analysis  of  culture  samples  taken 
before  and  after  induction  with  200  μmol  dm-3 of  IPTG.  Both  wild  type  Sec13  and  Sec13 
(AA12I→F) had high expression regardless of the coexpression partner. Expression of Nup145C 
was high when coexpressed with wild type Sec13 both when the His6-tag was attached to Sec13 
and  to  Nup145C.  When  Nup145C  was  coexpressed  with  His6-tagged  Sec13  (AA12I→F) 
expression of Nup145C was detected. The quality of SDS PAGE gels of samples containing other 
protein combinations was too low for direct detection of Sec311-748 or Nup145C expression from 
cell lysate. Sec13 expression was clearly detectable in these samples. Expression of Sec31372-411 
could not be tracked by SDS PAGE of cell lysates due to the small size of the peptide.
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Solubility
Both wild type Sec13 and the Sec13 (AA12I→F) mutant were present predominantly in the 
soluble fraction of the cell lysate. When coexpressed with wild type Sec13, Nup145C was also 
soluble.  Nup145C was found predominantly in  the insoluble  fraction of the cell  lysate  when 
coexpressed with Sec13 (AA12I→F) (Figure 17). Solubility of Sec311-748 and Sec31372-411 could not 
be monitored because of the low quality of SDS PAGE results.
Figure 17. Insoluble fractions of wild type 
Sec13 copurified with  His
6
-tagged 
Nup145C (lane 2) and  of Sec13 (AA12I→F) 
copurified with His
6
-tagged Nup145C
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
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Copurification on Ni-NTA agarose
Nup145C  copurified  readily  with  His6-tagged  wild  type  Sec13.  Copurification  of 
Nup145C with His6-tagged Sec13 (AA12I→F) was also observed, but with a far lower ratio of the 
Nup145C amount to the amount of Sec13 (Figure 18).
Wild type Sec13 copurified with His6-tagged Nup145C. A marked decrease in size was 
seen in His6-tagged Nup145C coexpressed with wild type Sec13 when compared to other SDS 
PAGE gels of Nup145C purifications.  The stained band of Nup145C shifted from a position 
corresponding to  ~81 kDa to  a new position corresponding to ~42 kDa in  size.  This can be 
explained by prolonged exposure to protease digestion, due to the particular conditions during the 
experiment.  Sec13 (AA12I→F)  copurified  with  His6-tagged  Nup145C to  a  much  lesser  extent 
(Figure 19). 
Expression  of  Sec311-748 was  too  low  for  direct  analysis  of  copurification.  Similarly 
Sec31372-411 was too small to be visualized on standard 10% SDS PAGE gels.
Figure 18. Coexpression and copurification of Nup145C with His
6
-tagged wild type 
Sec13 (lanes 2-8) and Sec13 (AA12I→F) (lanes 9-15). Lane 1: marker; lanes 2, 9: 
uninduced bacterial culture; lanes 3,10: induced bacterial culture; lanes 4, 11: soluble 
fraction of the cell lysate; lanes 5, 12: insoluble fraction of the cell lysate;  lanes 6, 
13: Ni-NTA column flow trough; lanes  7, 14: Ni-NTA column wash fractions; lanes 
8, 15:  Ni-NTA column eluates
27.0 kDa
34.6  kDa
42.7 kDa
55.6  kDa
66.4 kDa
97.2 kDa
Figure 19. Ni-NTA column eluates of  wild 
type Sec13 copurified with  His
6
-tagged 
Nup145C (lane 2) and  of Sec13 (AA12I→F) 
copurified with His
6
-tagged Nup145C
27.0 kDa
34.6  kDa
42.7 kDa
55.6  kDa
66.4 kDa
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Gel filtration
Gel  filtration  chromatography  provided  further  data  on  protein  binding  and 
expression levels. In the chromatogram of Ni-NTA agarose eluate containing His6-tagged wild 
type Sec13 copurified with Nup145C, three peaks were visible. A major peak, appearing at ~220 
ml of elution volume was shown by SDS PAGE to contain one protein, corresponding in size to 
Sec13. A minor peak appearing at  ~160 ml of elution volume was shown by SDS PAGE to 
contain two proteins. One protein corresponded in size to Sec13 while the other corresponded to 
Nup145C. A third peak, partially merged with the minor peak, appeared at ~175 ml of elution 
B)
C)
B)
C)
Figure 21. A) Gel filtration chromatogram of chromatogram of Ni-
NTA agarose eluate containing His
6
-tagged Sec13 (AA12I→F) 
copurified with Nup145C  B) SDS PAGE of fractions B1-B14 C)  
SDS PAGE of fractions C8-D1; Lane 1 is the protein marker in both 
B and C
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
34.6 kDa
27.0 kDa
42.7 kDa
55.6 kDa
66.4 kDa
97.2 kDa
A)
A)
Figure 20. A) Gel filtration chromatogram of of Ni-NTA agarose 
eluate containing His
6
-tagged wild type Sec13 copurified with 
Nup145C B) SDS PAGE of fractions B2-B15 C)  SDS PAGE of 
fractions C7-D2; Lane 1 is the protein marker in both B and C
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
97.2 kDa
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volume. Fractions belonging to this peak were shown by SDS PAGE to contain two proteins. One 
protein,  again,  corresponded  in  size  to  Sec13.  The  other  protein  was  estimated  to  have  a 
molecular mass of approximately 55 kDa. This protein is believed to be a degradation product of 
Nup145C, due to the numerous bands of intermediate sizes gradually appearing in the fractions 
corresponding to the transition between the 160 ml and the 175 ml peaks (Figure 20). 
The three peaks that were observed in the chromatogram of Ni-NTA agarose eluate 
containing His6-tagged wild type Sec13 copurified with Nup145C could also be detected in the 
chromatogram of  Ni-NTA agarose eluate  containing  His6-tagged Sec13 (AA12I→F)  copurified 
with Nup145C. The relative intensities of the peaks were, however, different (Figure 21). The 
peak appearing at ~175 ml of eluate was better resolved from the ~160 ml. The compositions of 
the three peaks, as examined by SDS PAGE, were the same as in the peaks observed from the 
chromatogram of Ni-NTA agarose eluate containing His6-tagged wild type Sec13 copurified with 
Nup145C.
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In  the chromatogram of  Ni-NTA agarose eluate  containing  His6-tagged Nup145C 
copurified with wild type Sec13, two peaks could be observed. A major peak appeared at ~180 
ml of elution volume. This peak was shown by SDS PAGE analysis to contain two proteins: one 
corresponding in size to Sec13 and a ~45 kDa protein. The ~45 kDa protein is believed to be a 
Nup145C degradation product, as the same protein was observed during purification on Ni-NTA 
agarose (Figure 19). Fractions taken from a second, minor peak that could be observed at ~220 
ml of elution volume contained only one protein that corresponded to Sec13 in molecular mass as 
estimated from SDS PAGE analysis (Figure 22).
The  chromatogram  of  Ni-NTA  agarose  eluate  containing  His6-tagged  Nup145C 
copurified  with  Sec13  (AA12I→F)  had  three  peaks.  All  of  these  were  of  low  intensity  and 
contained proteins with several different molecular masses, presumed to be impurities(Figure 23).
Figure 22. A) Gel filtration chromatogram of Ni-NTA 
agarose eluate containing His
6
-tagged Nup145C copurified 
with wild type Sec13  B) SDS PAGE of fractions B11-C5, 
C11-C14
A)
B)
C)
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
97.2 kDa
Figure 23. A) Gel filtration chromatogram of Ni-NTA agarose 
eluate containing His
6
-tagged Nup145C copurified with Sec13 
(AA12I→F) B) SDS PAGE of fractions A14-B5, B13-C4,  C)  SDS 
PAGE of fractions C5-C14; Lane 1 is the protein marker in both B 
and C
A)
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDaB)
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Four  peaks  could,  be  observed  in  the  chromatogram  of  Ni-NTA  agarose  eluate 
containing His6-tagged Sec311-748 copurified with wild type  Sec13. A major peak appeared at 
~110 ml of elution volume. Fractions corresponding to this peak were shown by SDS PAGE to 
contain two proteins with estimated molecular masses of ~85 kDa and ~33 kDa. These agree well 
with molecular masses of 83.5 kDa for Sec31 and 33 kDa for Sec13. The three minor peaks were 
shown to contain proteins of several different molecular masses, presumed to be contaminants 
from copurification  on Ni-NTA agarose.  A peak that  appeared  at  220 ml  of  elution  volume 
contained a protein with a molecular mass of ~33 kDa, believed to be Sec13 (Figure 24). 
The  chromatogram  of  Ni-NTA  agarose  eluate  containing  His6-tagged  Sec311-748 
copurified with Sec13 (AA12I→F) was quite similar to that of His6-tagged Sec311-748 copurified 
with wild type Sec13. The only notable difference was a fifth peak that appeared at ~195 ml of 
elution volume and was partially merged with the peaks appearing at ~180 ml and ~220 ml of 
elution volume (Figure 25). 
The gel filtrations of Ni-NTA agarose eluates containing His6-tagged Sec31372-411 copurified with 
wild type Sec13 or Sec13 (AA12I→F) served for assessment of the ability Sec31372-411 of to bind 
Sec13. The chromatogram of Ni-NTA agarose eluate containing His6-tagged Sec311-748 copurified 
with wild type Sec13 displayed a single peak at ~160 ml of elution volume. SDS PAGE analysis 
on 16.5% polyacrylamide gels showed that the fractions corresponding to this peak contained 
42.7 kDa
B)
A)
Figure 25. A) Gel filtration chromatogram of Ni-NTA agarose 
eluate containing His
6
-tagged Sec311-748   copurified with  Sec13 
(AA12I→F)  B) SDS PAGE of fractions A3-A6. Lane 1 is the 
protein marker
27.0 kDa
34.6 kDa
42.7 kDa
55.6 kDa
66.4 kDa
97.2 kDa
A)
B)
Figure 24. A) Gel filtration chromatogram of Ni-NTA 
agarose eluate containing His
6
-tagged Sec311-748  copurified 
with wild type Sec13 B) SDS PAGE of fractions A1-A9, 
A14-B3. Lane 1 is the protein marker
27.0 kDa
34.6 kDa
55.6 kDa
66.4 kDa
97.2 kDa
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three protein species, appearing in two peaks of protein concentration (as estimated from SDS 
PAGE).  A protein with an estimated  molecular  mass  of ~26 kDa formed a minor  peak that 
appeared at ~150 ml of elution volume. A second protein species with an estimated molecular 
mass of ~33 kDa (close to the molecular mass of Sec13), was present in fractions collected from 
~145 ml to ~180 ml of elution volume and formed a peak at 160 ml of elution volume. A third 
protein species was detectable in fraction collected from ~155 ml to ~165 ml of elution volume, 
reaching a peak concentration at ~160 ml of elution volume. This protein species had a molecular 
mass bellow 6.5 kDa, in frame with the size of the Sec31372-411 fragment (4.3 kDa) (Figure 26). 
In the chromatogram of Ni-NTA agarose eluate containing His6-tagged Sec31372-411 
copurified with Sec13 (AA12I→F), two peaks could be observed. A major peak appeared at ~165 
ml of elution volume. Eluate fractions belonging to this  peak were shown by SDS PAGE to 
contain a ~33 kDa protein, corresponding to Sec13. A second protein that produced much weaker 
bands at ~26 kDa is believed to be a contaminant from purification on Ni-NTA agarose. Some of 
the samples forming the peak displayed additional bands in SDS PAGE gels. These bands did not 
appear in neighboring samples and were therefore disregarded from analysis (Figure 27). 
Figure 27. A) Gel filtration chromatogram of Ni-NTA agarose eluate 
containing His
6
-tagged Sec13 (AA12I→F) copurified with Sec31372-411  B) 
SDS PAGE of fractions A2-A4, B4-B13. Lane 1 is the protein marker
6.5   kDa
14.3 kDa
20.0 kDa
27.0 kDa
34.6 kDa
A)
B)B)
A)
Figure 26. A) Gel filtration chromatogram of Ni-NTA agarose 
eluate containing His
6
-tagged wild type Sec13 copurified with 
Sec31372-411  B) SDS PAGE of fractions B2-B13. Lane 1 is the 
protein marker
6.5   
14.3 
20.0 
27.0 
34.6 
42.7 
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Discussion
Crystal structure determination
Expression  of  Sec13/Nup145C(109-179)  fusion  protein  was  sufficient  for  performing 
crystallization experiments.  A combination  of His6-tagged protein affinity purification  on Ni-
NTA agarose combined with gel filtration chromatography provided Sec13/Nup145C(109-179) 
fusion  protein  samples  of  high  purity  for  crystallization  experiments.  During  cell  lysis  and 
subsequent  protein  affinity  purification,  a  buffer  containing  20  mM  imidazole  was  used  ,as 
protein binding to Ni-NTA agarose was significantly less efficient in buffers containing higher 
concentrations of imidazole.
Seeding experiments proved useful for improvement of crystal morphology and increase 
in  size.  Full-grown crystals  were  usually  observed  one  day  after  setting  of  the  experiment. 
Typically, a membranous layer enveloping the drop containing a mix of protein and precipitant 
could be seen. Protein crystals grew attached to this layer. During removal of crystals from drops, 
this layer tore into peaces that rapidly consolidated to form additional protein crystals. 
A dataset with diffraction maxima up to a resolution of 2.45 Å was obtained. This was 
deemed sufficient for comparative analysis of the Sec13-Nup145C interface. Since two structures 
of yeast Sec13 have already been solved, the molecular replacement method was used for phase 
determination. Modeling of protein sequence into the electron density map was successful for 
most parts of the protein. Exceptions were two regions presumed to be highly mobile loops, the 
region linking the carboxy terminal part of Sec13 to the amino terminus of Nup145C and an 
amino  terminal  segment  of  the  construct.  Several  lysine  side  chains  could  not  be 
straightforwardly modeled into the electron density map.
The molecular structure revealed several inter-protein contacts. These were indicated by 
PISA  to  be  crystal  contacts,  probably  without  physiological  significance.  These  results  are 
supported by the fact that the Sec13/Nup145C(109-179) fusion protein behaved as a monomer 
during gel filtration. Protein contacts might be one of the reasons for rapid formation of protein 
crystals.
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The structure of the construct is a seven bladed β-propeller, having a donut-like shape, 
with  a  central  cavity  extending  from  the  side  of  the  protein  facing  the  amino-terminus  of 
Nup145C, roughly half-way along the axes of the structure. Further down the central axes, an 
isolated, solvent filled cavern is found. Six blades of the propeller, composed of four β-strands 
each,  are  parts  of  Sec13.  The seventh  blade contains  three  β-strands  and is  provided  by the 
carboxy  terminal  region  of  the  Nup145C insertion  fragment.  The  only  α-helical  part  of  the 
structure is the amino terminal α-helix of the Nup145C fragment. The α-helix and insertion blade 
of Nup145C are linked by a seven amino acid long region lacking a defined secondary structure. 
Exceptionally conserved regions of the protein tend to be those that are structurally or 
functionally  significant  (Gruber  et  al.,  2007).  Analysis  of  sequence conservation  reveals  that 
solvent-exposed segments  of  the β-propeller  blades  tend  to  be  less  conserved,  resulting  in  a 
surface mostly lacking large conserved regions.  The area surrounding the Nup145C insertion 
blade, the surface facing the amino-terminal α-helix of the Nup145C domain invasion motif and 
the surface lining the entrance into the central cavity form the only continuous conserved areas. 
Large, charged patches of protein surface may indicate functionally important sites (Voet 
and Voet, 2004). Surface charge distribution for the Sec13/Nup145C(109-179) fusion protein is 
roughly uniform, with large neutral regions interrupted by a roughly equal number of positively 
and negatively charged patches.
The temperature factor (B-factor) is proportional to structural flexibility and is thus an 
important indicator of dynamic regions within protein structures (Drenth, 2007). An examination 
of the B-factor distribution reveals that the interior regions of the protein construct are more rigid 
than the segments on the periphery of the structure. Several parts of the structure, including the 
Nup145C amino terminal α-helix and several loops, are exceptionally mobile. Observation of the 
B-factors for loops that could not be fully modeled into the structure (i.e. loops linking β-strands 
11-12 and 13-14) revealed them to be highly mobile, suggesting that the lack of electron density 
for these loops was indeed a consequence of high mobility.
Nup145C is bound to Sec13 through heterotypic interactions, including two salt bridges, 
numerous hydrogen bonds and hydrophobic contacts. Several structurally bound water molecules 
are visible in the interface. 
Comparison  of  the  Sec13-Nup145C  interface  to  the  Sec13-Sec31  interface  revealed 
differences in binding of Sec13 to its two interacting partners. While the hydrogen bonds and 
electrostatic interactions binding Sec13 to Sec31 are fairly similar to those in the Sec13-Nup145C 
61
interface  (e.g.  Sec13  amino  acids  Asp205  and  Asp14  form  salt  bridge  pairs  with  similarly 
positioned  positively charged amino acids in both complexes),  positions and types  of amino 
acids involved in hydrophobic contacts do not appear to be conserved. 
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Sec13 mutant design and binding analysis
Lack of  conservation  between the  Sec13-Sec31 and the  Sec13-Nup145C hydrophobic 
contacts  was used for design of a mutant that would specifically disrupt the Sec13-Nup145C 
interactions,  without  having  an effect  on Sec13-Sec31 binding.  A mutation  that  changed the 
Sec13 amino acid Ile12 into a phenylalanine,  Sec13 (AA12I→F),  was hypothesized to sterically 
hinder Sec13-Nup145C binding. Since Ile12 is part of a hydrophobic pocket binding Nup145C 
amino acids Phe144,  Tyr148 and Phe150,  this mutation was believed to lead to the disruption of 
Sec13-Nup145C interaction. Since the analogous sequence in Sec31 (amino acids 378-384) lacks 
amino acids with aromatic side chains, the corresponding region in the Sec13-Sec31 complex 
should contain enough space to accommodate a phenylalanine side chain.
This hypothesis  was tested by copurification experiments.  Wild type Sec13 and Sec13 
(AA12I→F) were each coexpressed with either Nup145C, Sec31372-411 (containing only the Sec31 
insertion blade) or Sec311-748 (this construct contains all the domains involved in binding Sec13). 
The proteins were copurified on Ni-NTA agarose and further run through gel filtration columns. 
All fractions from the Ni-NTA copurification and gel filtration chromatography were analyzed on 
SDS PAGE gels.
Results demonstrated that the Sec13 (AA12I→F) had similar expression levels as wild type 
Sec13. Further, both proteins were equally soluble and displayed the same properties during gel 
filtration chromatography, demonstrating that the AA12I→F mutation did not radically effect the 
structure of Sec13.
Expression of Sec311-748 was too low for determination of binding from the results of Ni-
NTA purification. Gel filtration chromatography revealed that both wild type Sec13 and Sec13 
(AA12I→F) copurified with Sec311-748 in similar amounts. Both types of Sec13 appeared in the 
same gel filtration chromatography fractions as Sec311-748, confirming that the Sec13 (AA12I→F) 
mutation is not disruptive to Sec13-Sec31 binding.
Copurification of wild type Sec13 and Sec13 (AA12I→F) with Sec31372-411, again, could not 
be assessed directly from the results of purification on Ni-NTA agarose. Due to the small size of 
Sec31372-411 (~4.3 kDa) samples had to be analyzed on high density (16.5%) SDS PAGE gels. 
Since analysis on 16.5% SDS PAGE gels requires high sample purity, relatively impure samples 
purified on Ni-NTA agarose did not return clear results. Gel filtration chromatography revealed 
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that wild type Sec13 copurified with Sec31372-411 on Ni-NTA agarose. Both proteins appeared in 
the same elution fractions, indicating that they traveled through the gel filtration column as a 
complex.  The  same  results  could  not  be  repeated  for  Sec31372-411 coexpressed  with  Sec13 
(AA12I→F).
The fact that the Sec13 (AA12I→F) mutant binds Sec311-748, but does not detectably bind 
Sec31372-411, indicates that the Sec31 insertion fragment alone cannot account for the Sec13-Sec31 
interaction. Since no interactions between Sec13 and the amino and carboxy terminal domains of 
Sec31 were observed in the crystal  structures, it  is improbable (although not impossible) that 
these two domains of Sec31 enhance Sec13-Sec311-748 binding. Changed orientations of amino 
acid side chains in the two Sec13-Sec31 structures might provide an explanation for this effect. In 
the structure of Sec13 bound to the Sec31 amino terminal β-propeller domain, a salt bridge is 
formed between the Sec13 amino acid Arg259 and the Sec31 amino acid Glu379. In the structure of 
Sec13 bound to the carboxy terminal,  α-helical  domain of Sec31, Glu379 is part of the amino 
terminal region of the molecule and its side chain is oriented towards the bulk solvent, severing a 
salt bridge. Since Glu379  would also be part of the amino terminus in Sec31372-411, but not in 
Sec311-748,  it  is  possible  that  a  similar  situation  occurs  in  these  two  constructs.  Additional 
experiments with mutants of Sec31 Glu379 are necessary to investigate this hypothesis.
When Nup145C was coexpressed with wild type Sec13, expression of Sec13 was much 
higher  than  that  of  Nup145C,  although  both  proteins  had  high  expression  levels.  Nup145C 
copurified on Ni-NTA agarose with wild type Sec13. Both Nup145C and Sec13 appeared in the 
same fractions of gel filtration eluates,  indicating that they traveled through the column as a 
single complex. A large peak of pure Sec13 was also observed. This could be explained by the 
higher  expression  levels  of  Sec13.  To  verify  this  hypothesis,  His6-tagged  Nup145C  was 
coexpressed  with  tag-free  Sec13  and  the  lysate  was  purified  on  Ni-NTA  agarose.  The  gel 
filtration chromatogram of the Ni-NTA elution contained a large peak that was shown by SDS-
PAGE to contain Sec13 and Nup145C. A small peak corresponding to non-bound Sec13 was 
observed, signifying that some Sec13 had dissociated from Nup145C or that Sec13 could non-
specifically bind Ni-NTA agarose.
Nup145C coexpressed with Sec13 (AA12I→F) was found mostly in the insoluble fraction 
of the cell lysate. Since Nup145C alone is not soluble  in vitro this was an indication that the 
Sec13 (AA12I→F) mutant disrupted Nup145C binding. However, a small fraction of Nup145C did 
copurify with Sec13 (AA12I→F) on Ni-NTA agarose. Further, a small peak containing Nup145C 
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bound to Sec13 (AA12I→F) could be detected in the gel filtration chromatograms of the the Ni-
NTA eluates. This peak was significantly smaller than the corresponding peak in chromatogram 
of the wild type Sec13-Nup145C complex. A large peak of pure Sec13 was also observed.
A gel filtration chromatogram of His6-tagged Nup145C coexpressed with tag-free Sec13 
(AA12I→F) contained peaks of very low intensity, which were shown by SDS PAGE to contain 
several proteins of different molecular masses, most probably impurities.
Together,  the  copurification  and  gel  filtration  data  indicate  that,  while  the  Sec13 
(AA12I→F) mutation does not completely impair Sec13-Nup145C binding it significantly reduces 
the  affinity  of  Sec13  for  Nup145C.  The  physiological  significance  of  the  Sec13  (AA12I→F) 
mutation remains to be determined. Green-fluorescent protein (GFP)-tagged protein fluorescence 
localization an yeast growth assays are possible methods for assessing the affinity of the Sec13 
(AA12I→F) mutant for Nup145C in vivo.
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Conclusions
• A crystal  structure  of  yeast  Sec13  bound  to  the  yeast  Nup145C insertion  blade  was 
successfully determined.
• Comparison with known structures of Sec13 confirmed general structural conservation of 
the seven bladed β-propeller fold. 
• Comparison of the yeast Sec13- yeast Sec31 and yeast Sec13-yeast Nup145C interaction 
interfaces  revealed several  conserved polar  contacts,  but  also found a  general  lack of 
conservation in the arrangement of hydrophobic contacts.
• Based on the known crystal structures of Sec13-containing complexes, a Sec13 (AA12I→F) 
mutant, that was proposed to selectively disrupt the Sec13-Nup145C interaction without 
affecting Sec13 binding to Sec31, was designed.
• Effect of the Sec13 (AA12I→F) mutant on Sec13 affinities for Nup145C and Sec31 was 
examined  by  copurification  on  Ni-NTA  agarose  followed  by  gel  filtration 
chromatography.  The mutation was confirmed to significantly affect  Sec13 binding to 
Nup145C without disrupting the Sec13-Sec31 interaction.
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